LivePerson (LPSN) 10-Q 6 Aug 24 2024 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2024	Aug. 02, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2024
Document Transition Report	false
Entity File Number	000-30141
Entity Registrant Name	LIVEPERSON, INC.
Entity Central Index Key	0001102993
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	13-3861628
Entity Address, Address Line One	530 7th Ave, Floor M1
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10018
City Area Code	(212)
Local Phone Number	609-4200
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		89,019,738
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	LPSN
Security Exchange Name	NASDAQ
Rights to Purchase Series A Junior Participating Preferred Stock
Document Information [Line Items]
No Trading Symbol Flag	true
Title of 12(b) Security	Rights to Purchase Series A JuniorParticipating Preferred Stock
Security Exchange Name	NASDAQ
No Trading Symbol Flag	true

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 145,957	$ 210,782
Restricted cash	0	2,143
Accounts receivable, net of allowance for credit losses of $9,356 and $9,290 as of June 30, 2024 and December 31, 2023, respectively	56,351	81,802
Prepaid expenses and other current assets (Note 1)	18,132	26,981
Total current assets	220,440	321,708
Operating lease right-of-use assets (Note 9)	260	4,135
Property and equipment, net (Note 6)	106,948	119,325
Contract acquisition costs, net	36,864	37,354
Intangible assets, net (Note 5)	52,956	61,625
Goodwill (Note 5)	280,726	285,631
Deferred tax assets	4,441	4,527
Other assets	1,133	1,208
Total assets	703,768	835,513
Current liabilities:
Accounts payable	13,878	13,555
Accrued expenses and other current liabilities (Note 7)	68,237	97,024
Deferred revenue (Note 2)	79,356	81,858
Convertible senior notes (Note 8)	0	72,393
Operating lease liabilities (Note 9)	268	2,719
Total current liabilities	161,739	267,549
Convertible senior notes, net of current portion (Note 8)	468,666	511,565
Operating lease liabilities, net of current portion (Note 9)	0	2,173
Deferred tax liabilities	3,075	2,930
Other liabilities	3,682	3,158
Total liabilities	637,162	787,375
Commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock, $0.001 par value - 5,000,000 shares authorized, none issued	0	0
Common stock, $0.001 par value - 200,000,000 shares authorized, 91,752,520 and 90,603,519 shares issued, 88,986,447 and 87,837,446 shares outstanding as of June 30, 2024 and December 31, 2023, respectively.	92	91
Treasury stock - 2,766,073 shares as of June 30, 2024 and December 31, 2023	(3)	(3)
Additional paid-in capital	927,529	913,522
Accumulated deficit	(850,824)	(856,988)
Accumulated other comprehensive loss	(10,188)	(8,484)
Total stockholders’ equity	66,606	48,138
Total liabilities and stockholders’ equity	$ 703,768	$ 835,513

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) $ in Thousands	Jun. 30, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares
Statement of Financial Position [Abstract]
Accounts receivable, allowances including credit loss and sales reserve | $	$ 9,356	$ 9,290
Preferred stock, par value (in dollars per share) | $ / shares	$ 0.001	$ 0.001
Preferred stock, authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares outstanding (in shares)	0	0
Preferred stock, issued (in shares)	0	0
Common stock, authorized (in shares)	200,000,000	200,000,000
Common stock, issued (in shares)	91,752,520	90,603,519
Common stock, outstanding (in shares)	88,986,447	87,837,446
Treasury stock (in shares)	2,766,073	2,766,073

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Revenue	$ 79,875,000	$ 97,522,000	$ 165,024,000	$ 205,183,000
Costs, expenses and other:
Cost of revenue	21,212,000	30,888,000	50,675,000	73,984,000
Sales and marketing	26,473,000	26,724,000	56,603,000	61,194,000
General and administrative	24,448,000	8,170,000	46,200,000	39,617,000
Product development	24,843,000	22,839,000	54,963,000	59,358,000
Impairment of goodwill	0	0	3,627,000	0
Impairment of intangibles and other assets	8,347,000	0	10,568,000	0
Restructuring costs	3,119,000	2,387,000	6,428,000	13,902,000
Gain on divestiture	558,000	0	558,000	(17,591,000)
Amortization of purchased intangible assets	674,000	876,000	1,565,000	1,750,000
Total costs, expenses and other	109,674,000	91,884,000	231,187,000	232,214,000
(Loss) income from operations	(29,799,000)	5,638,000	(66,163,000)	(27,031,000)
Other income (expense), net:
Interest (expense) income, net	(837,000)	136,000	495,000	1,937,000
Gain on debt extinguishment	73,083,000	1,151,000	73,083,000	7,200,000
Other income, net	606,000	3,742,000	369,000	12,355,000
Total other income	72,852,000	5,029,000	73,947,000	21,492,000
Income (loss) before provision for (benefit from) income taxes	43,053,000	10,667,000	7,784,000	(5,539,000)
Provision for (benefit from) income taxes	1,258,000	(155,000)	1,620,000	1,059,000
Net Income (loss)	$ 41,795,000	$ 10,822,000	$ 6,164,000	$ (6,598,000)
Net loss per share of common stock:
Basic (in dollars per share)	$ 0.47	$ 0.14	$ 0.07	$ (0.09)
Diluted (in dollars per share)	$ (0.33)	$ 0.12	$ (0.70)	$ (0.09)
Weighted average shares outstanding:
Basic (in shares)	88,708,514	76,902,416	88,396,816	76,341,729
Diluted (in shares)	94,978,234	91,500,059	94,973,001	76,341,729

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 41,795	$ 10,822	$ 6,164	$ (6,598)
Foreign currency translation adjustment	(6)	386	(1,704)	1,252
Comprehensive income (loss)	$ 41,789	$ 11,208	$ 4,460	$ (5,346)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock, Common	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022		78,350,984	(2,766,073)
Beginning balance at Dec. 31, 2022	$ 68,088	$ 78	$ (3)	$ 771,052	$ (692,362)	$ (10,677)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		18,687
Common stock issued upon exercise of stock options	130			130
Common stock issued upon vesting of restricted stock units (in shares)		413,252
Common stock issued upon vesting of restricted stock units	1	$ 1
Stock-based compensation	9,560			9,560
Common stock issued under Employee Stock Purchase Plan (in shares)		87,794
Common stock issued under Employee Stock Purchase Plan (ESPP)	724			724
Issuance of common stock in connection with acquisitions (Note 9)	380			380
Activity related to divestiture (Note 20)	2,732			66,775	(64,100)	57
Net income (loss)	(17,420)				(17,420)
Other comprehensive loss	809					809
Ending balance (in shares) at Mar. 31, 2023		78,870,717	(2,766,073)
Ending balance at Mar. 31, 2023	65,004	$ 79	$ (3)	848,621	(773,882)	(9,811)
Beginning balance (in shares) at Dec. 31, 2022		78,350,984	(2,766,073)
Beginning balance at Dec. 31, 2022	68,088	$ 78	$ (3)	771,052	(692,362)	(10,677)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(6,598)
Ending balance (in shares) at Jun. 30, 2023		80,312,090	(2,766,073)
Ending balance at Jun. 30, 2023	90,145	$ 80	$ (3)	862,553	(763,060)	(9,425)
Beginning balance (in shares) at Mar. 31, 2023		78,870,717	(2,766,073)
Beginning balance at Mar. 31, 2023	65,004	$ 79	$ (3)	848,621	(773,882)	(9,811)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		11,154
Common stock issued upon exercise of stock options	8			8
Common stock issued upon vesting of restricted stock units (in shares)		295,564
Common stock issued upon vesting of restricted stock units	0
Stock-based compensation	8,380			8,380
Common stock issued under Employee Stock Purchase Plan (in shares)		97,832
Common stock issued under Employee Stock Purchase Plan (ESPP)	397			397
Issuance of common stock in connection with acquisitions (in shares)		1,036,823
Issuance of common stock in connection with acquisitions (Note 9)	5,148	$ 1		5,147
Net income (loss)	10,822				10,822
Other comprehensive loss	386					386
Ending balance (in shares) at Jun. 30, 2023		80,312,090	(2,766,073)
Ending balance at Jun. 30, 2023	90,145	$ 80	$ (3)	862,553	(763,060)	(9,425)
Beginning balance (in shares) at Dec. 31, 2023		90,603,519	(2,766,073)
Beginning balance at Dec. 31, 2023	48,138	$ 91	$ (3)	913,522	(856,988)	(8,484)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon vesting of restricted stock units (in shares)		432,701
Common stock issued upon vesting of restricted stock units	1			1
Stock-based compensation	8,251			8,251
Common stock issued under Employee Stock Purchase Plan (in shares)		95,603
Common stock issued under Employee Stock Purchase Plan (ESPP)	122			122
Net income (loss)	(35,631)				(35,631)
Other comprehensive loss	(1,698)					(1,698)
Ending balance (in shares) at Mar. 31, 2024		91,131,823	(2,766,073)
Ending balance at Mar. 31, 2024	19,183	$ 91	$ (3)	921,896	(892,619)	(10,182)
Beginning balance (in shares) at Dec. 31, 2023		90,603,519	(2,766,073)
Beginning balance at Dec. 31, 2023	48,138	$ 91	$ (3)	913,522	(856,988)	(8,484)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	6,164
Ending balance (in shares) at Jun. 30, 2024		91,752,520	(2,766,073)
Ending balance at Jun. 30, 2024	66,606	$ 92	$ (3)	927,529	(850,824)	(10,188)
Beginning balance (in shares) at Mar. 31, 2024		91,131,823	(2,766,073)
Beginning balance at Mar. 31, 2024	19,183	$ 91	$ (3)	921,896	(892,619)	(10,182)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon vesting of restricted stock units (in shares)		536,424
Common stock issued upon vesting of restricted stock units	2	$ 1		1
Stock-based compensation	5,762			5,762
Common stock issued under Employee Stock Purchase Plan (in shares)		84,273
Common stock issued under Employee Stock Purchase Plan (ESPP)	55			55
Activity related to divestiture (Note 20)	(185)			(185)
Net income (loss)	41,795				41,795
Other comprehensive loss	(6)					(6)
Ending balance (in shares) at Jun. 30, 2024		91,752,520	(2,766,073)
Ending balance at Jun. 30, 2024	$ 66,606	$ 92	$ (3)	$ 927,529	$ (850,824)	$ (10,188)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
OPERATING ACTIVITIES:
Net income (loss)	$ 41,795,000	$ (35,631,000)	$ 10,822,000	$ (17,420,000)	$ 6,164,000	$ (6,598,000)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Stock-based compensation expense					13,458,000	(6,816,000)
Depreciation					15,939,000	17,088,000
Reduction of operating lease right-of-use assets					3,886,000	1,211,000
Amortization of purchased intangible assets and finance leases					7,899,000	10,889,000
Amortization of debt issuance costs and debt discount					1,343,000	2,727,000
Impairment of goodwill	0		0		3,627,000	0	$ 11,895,000
Impairment of intangibles and other assets	8,347,000		0		10,568,000	0
Change in fair value of contingent consideration					0	(5,304,000)
Gain on debt extinguishment					(73,083,000)	(7,200,000)
Allowance for credit losses		3,319,000			8,928,000	1,809,000
Gain on divestiture					558,000	(17,591,000)
Deferred income taxes					199,000	722,000
Equity loss in joint venture					0	1,384,000
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable					16,247,000	(20,537,000)
Prepaid expenses and other current assets					8,673,000	(9,126,000)
Contract acquisition costs					7,000	3,534,000
Other assets					47,000	75,000
Accounts payable					629,000	(19,757,000)
Accrued expenses and other current liabilities					(35,894,000)	16,737,000
Deferred revenue					(2,269,000)	15,652,000
Operating lease liabilities					(4,542,000)	(1,648,000)
Other liabilities					784,000	(7,800,000)
Net cash used in operating activities					(16,832,000)	(30,549,000)
INVESTING ACTIVITIES:
Purchases of property and equipment, including capitalized software					(16,457,000)	(16,997,000)
Purchases of intangible assets					(1,259,000)	(2,457,000)
Proceeds from divestiture					0	13,819,000
Net cash used in investing activities					(17,716,000)	(5,635,000)
FINANCING ACTIVITIES:
Principal payments for financing leases	(26,000)		(968,000)		(353,000)	(1,926,000)
Proceeds from issuance of common stock in connection with the exercise of options and ESPP					180,000	1,256,000
Proceeds from issuance of senior notes					50,000,000	0
Payments of Debt Issuance Costs					(4,231,000)	0
Net cash used in financing activities					(31,797,000)	(150,372,000)
Effect of foreign exchange rate changes on cash and cash equivalents					(623,000)	789,000
Net decrease in cash, cash equivalents, and restricted cash					(66,968,000)	(185,767,000)
Cash, cash equivalents, and restricted cash - beginning of year		$ 212,925,000		$ 392,198,000	212,925,000	392,198,000	392,198,000
Plus: cash classified within current assets held for sale - beginning of year							0	$ 10,011,000
Cash, cash equivalents, and restricted cash - end of period	145,957,000		216,442,000		145,957,000	216,442,000	212,925,000
Reconciliation of cash, cash equivalents, and restricted cash to condensed consolidated balance sheets
Cash and cash equivalents	145,957,000		213,763,000		145,957,000	213,763,000	210,782,000
Restricted cash	0		2,679,000		0	2,679,000	2,143,000
Total cash, cash equivalents, and restricted cash	$ 145,957,000		$ 216,442,000		145,957,000	216,442,000	$ 212,925,000	$ 392,198,000
Supplemental disclosure of other cash flow information:
Cash paid for income taxes, net					1,203,000	1,112,000
Cash paid for interest					292,000	904,000
Supplemental disclosure of non-cash investing and financing activities:
Purchase of property and equipment and intangible assets recorded in accounts payable					154,000	581,000
Right-of-use assets obtained in exchange for operating lease liabilities					107,000	132,000
2024 Notes
FINANCING ACTIVITIES:
Payments on repurchase of 2024 convertible senior notes					(72,492,000)	(149,702,000)
2026 Notes
FINANCING ACTIVITIES:
Payments on repurchase of 2024 convertible senior notes					$ (4,901,000)	$ 0

Description of Business and Bas

Description of Business and Basis of Presentation	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business and Basis of Presentation	Description of Business and Basis of Presentation LivePerson, Inc. (“LivePerson”, the “Company”, “we”, “our” or “us”) is the enterprise leader in digital customer conversations. Over the past two decades, consumers have made digital conversations their primary mode of communication with others. Since 1998, we have enabled meaningful connections between consumers and our customers through our platform and currently power more than one billion conversational interactions each month. These digital and artificial intelligence (“AI”)-powered conversations decrease costs and increase revenue for our brands, resulting in more convenient, personalized and content-rich journeys across the entire consumer lifecycle, and across consumer channels. Our customers’ existing investments in Generative AI and Large Language Models (“LLMs”) can be used by LivePerson to leverage prior conversations in a safe and secure environment. The Conversational Cloud, LivePerson’s enterprise-class digital customer conversation platform, is trusted by the world’s top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The Conversational Cloud powers conversations across each of a brand’s primary digital channels, including mobile apps, mobile and desktop web browsers, short messaging service (“SMS”), social media and third-party consumer messaging platforms. Brands can also use the Conversational Cloud to message consumers when they dial a 1-800 number instead of forcing them to navigate interactive voice response systems and wait on hold. Most recently, the Conversational Cloud has been enhanced to provide a secure platform with appropriate guardrails to deploy Generative AI and LLMs in ways that help consumers and drive results for brands without sacrificing trust. LivePerson’s digital customer conversation platform enables what the Company calls “the tango” of humans, LivePerson bots, third-party bots and LLMs, in which humans act as bot managers, overseeing AI-powered conversations and seamlessly stepping into the flow when a personal touch is needed. Agents become highly efficient, leveraging the AI engine (including generative AI capabilities) to surface relevant content, define next-best actions and take over repetitive transactional work so that the agent can focus on relationship building. By seamlessly integrating customer engagement channels, LivePerson’s proprietary AI, and third-party bots and AI, the Conversational Cloud offers brands a comprehensive approach to scaling automations across all customer conversations. Basis of Presentation The accompanying condensed consolidated financial statements, and the financial data and other information disclosed in the notes to the condensed consolidated financial statements as of June 30, 2024 and for the three and six months ended June 30, 2024 are unaudited. In the opinion of management, the unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for a fair presentation of the Company’s condensed consolidated financial position, results of operations, comprehensive loss, and cash flows for the interim periods presented. The results of operations for any interim period are not necessarily indicative of the results of operations for any other future interim period or for a full fiscal year. The condensed consolidated balance sheet as of December 31, 2023 has been derived from audited consolidated financial statements at that date. Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the year ended December 31, 2023 included in the Company’s Annual Report on Form 10-K filed with the SEC on March 4, 2024 (as amended on April 29, 2024) . Principles of Consolidation The unaudited condensed consolidated financial statements reflect the operations of LivePerson and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. These estimates are based on information available as of the date of the condensed consolidated financial statements. On a regular basis, management evaluates these estimates and assumptions. Items subject to such estimates and assumptions include, but are not limited to: • stock-based compensation expense; • allowance for credit losses; • the period of benefit for deferred contract acquisition costs; • valuation of goodwill; • valuation and useful lives of other long-lived assets; • fair value of assets acquired and liabilities assumed in business combinations; • income taxes; • recognition, measurement, and disclosure of contingent liabilities; and • estimated fair values of convertible notes and warrants. As of the date of issuance of the financial statements, the Company is not aware of any material specific events or circumstances that would require it to update its estimates, judgments, or to revise the carrying values of its assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the Company’s condensed consolidated financial statements. Significant Accounting Policies The Company’s significant accounting policies are described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. There have been no significant changes to these policies that have had a material impact on the Company’s condensed consolidated financial statements and related notes for the three and six months ended June 30, 2024. Prepaid expenses and other current assets The following table presents the detail of prepaid expenses and other current assets as of the dates presented: June 30, December 31, (In thousands) Prepaid software maintenance $ 8,189 $ 8,592 VAT receivable 4,177 4,399 Prepaid server maintenance 1,606 2,634 Prepaid - other 1,158 2,599 Other assets 3,002 8,757 Total prepaid expenses and other current assets $ 18,132 $ 26,981 Recently Adopted Accounting Pronouncements In June 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2022-03, Fair Value Measurement (Topic 820), Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions to clarify that a contractual restriction on the sale of an equity security is not considered part of a unit of account of the equity security, and, therefore, is not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The amendments also require the following disclosures for equity securities subject to the contractual sale restrictions: 1.) The fair value of equity securities subject to the contractual sale restrictions reflected on the balance sheet. 2.) The nature and remaining duration of the restriction(s). 3.) The circumstances that could cause a lapse in the restriction(s). This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within those financial years. The Company adopted this guidance on January 1, 2024, which did not have a material effect on the Company’s condensed consolidated financial statements. Recently Issued Accounting Pronouncements In March 2024, the FASB issued ASU 2024-01, Compensation—Stock Compensation (Topic 718) : Scope Application of Profits Interest and Similar Awards , which provides illustrative guidance to help entities determine whether profits interest and similar awards should be accounted for as share-based payment arrangements within the scope of FASB Accounting Standards Codification (“ASC”) 718, Compensation—Stock Compensation . Specifically, the amendments in ASU 2024-01 add an illustrative example that includes four fact patterns to demonstrate how an entity should apply the scope guidance in paragraph 718-10-15-3 to determine whether a profits interest award should be accounted for in accordance with Topic 718. The guidance in ASU 2024-01 applies to all entities that issue profits interest awards as compensation to employees or non-employees in exchange for goods or services. The amendments in this update are effective for annual periods beginning after December 15, 2024, and interim periods within those annual periods. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. ASU 2024-01 should be applied either retrospectively or prospectively. The Company does not expect this standard to have a material impact on its condensed consolidated financial statements and related disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. The updated standard is effective for annual periods beginning after December 15, 2023. As of June 30, 2024, the Company has one operating and reportable segment and therefore does not expect this standard to have a material impact on its condensed consolidated financial statements and related disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures , which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company does not expect this standard to have a material impact on its condensed consolidated financial statements and related disclosures. In August 2023, the FASB issued ASU 2023-05, Business Combinations—Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement , which addresses the accounting for contributions made to a joint venture, upon formation, in a joint venture’s separate financial statements. The amendments require certain joint ventures to apply a new basis of accounting upon formation by recognizing and initially measuring most of their assets and liabilities at fair value. The objectives of the amendments are to provide decision-useful information to investors and other allocators of capital in a joint venture’s financial statements and also to reduce diversity in practice. ASU 2023-05 is effective for both public and private joint venture entities with a formation date on or after January 1, 2025. Early adoption is permitted. Entities may elect to apply the guidance retrospectively to joint ventures with a formation date prior to

Revenue Recognition

Revenue Recognition	6 Months Ended
	Jun. 30, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition The majority of the Company’s revenue is generated from hosted service revenues, which is inclusive of its platform pricing model, and related professional services. Revenues are recognized when control of these services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. No single customer accounted for 10% or more of total revenue for the three and six months ended June 30, 2024 and 2023. The following table presents the Company’s revenues disaggregated by revenue source: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (In thousands) (In thousands) Revenue: Hosted services (1) $ 67,316 $ 81,286 $ 138,811 $ 168,624 Professional services 12,559 16,236 26,213 36,559 Total revenue $ 79,875 $ 97,522 $ 165,024 $ 205,183 (1) On March 20, 2023, the Company completed the sale of Kasamba and therefore ceased recognizing revenue related to Kasamba effective on the transaction close date. Further, this sale eliminated the entire Consumer segment, as a result of which revenue is presented within a single condensed consolidated segment. Hosted services includes $7.2 million of revenue related to Kasamba for the six months ended June 30, 2023. Remaining Performance Obligation As of June 30, 2024, the aggregate amount of the total transaction price allocated in contracts with original duration of one year or greater to the remaining performance obligations was $283.0 million. Approximately 94% of the Company’s remaining performance obligations is expected to be recognized during the next 24 months, with the balance recognized thereafter. The aggregate balance of unsatisfied performance obligations represents contracted revenue that has not yet been recognized, and does not include contract amounts that are cancellable by the customer, amounts associated with optional renewal periods, and any amounts related to performance obligations, which are billed and recognized as they are delivered. The Company has elected the optional exemption, which allows for the exclusion of the amounts for remaining performance obligations that are part of contracts with an original expected duration of less than one year. Such remaining performance obligations represent unsatisfied or partially unsatisfied performance obligations pursuant to ASC 606, “Revenue from Contracts with Customers.” Revenue by Geographic Location The Company is domiciled in the United States and has international operations around the globe. The following table presents the Company’s revenues attributable to operations by region for the periods presented: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (In thousands) (In thousands) Americas (1) $ 56,385 $ 70,907 $ 118,410 $ 143,221 EMEA (2) 14,559 14,933 28,780 31,115 APAC (3) 8,931 11,682 17,834 30,847 Total revenue $ 79,875 $ 97,522 $ 165,024 $ 205,183 —————————————— (1) United States, Canada, Latin America and South America (“Americas”) (2) Europe, the Middle East and Africa (“EMEA”) (3) Asia-Pacific (“APAC”) Information about Contract Balances The deferred revenue balance consists of services, which have been invoiced upfront, and are recognized as revenue only when the revenue recognition criteria are met. In some arrangements, the Company allows customers to pay for access to the Conversational Cloud over the term of the software license. The Company refers to these as subscription transactions. Amounts recognized as revenue in excess of amounts billed are recorded as unbilled receivables. Unbilled receivables, anticipated to be invoiced in the next twelve months, are included in accounts receivable, net of allowance for credit losses on the condensed consolidated balance sheets. The Company recognized revenue of $22.2 million and $64.7 million for the three and six months ended June 30, 2024, respectively, which was included in the corresponding deferred revenue balance at the beginning of the year. The Company recognized revenue of $28.9 million and $73.0 million for the three and six months ended June 30, 2023, respectively, which was included in the corresponding deferred revenue balance at the beginning of the year. Our long-term deferred revenues are included in Other liabilities on the condensed consolidated balance sheets. The opening and closing balances of the Company’s accounts receivable, unbilled receivables, contract acquisition costs, net, and deferred revenues are as follows: Accounts Receivable Unbilled Receivable Contract Acquisition Costs, Net (Non-current) Deferred Revenue (Current) Deferred Revenue (In thousands) Balance as of December 31, 2022 $ 53,468 $ 33,069 $ 43,804 $ 84,494 $ 174 Increase (decrease), net 6,914 (11,649) (6,450) (2,636) 9 Balance as of December 31, 2023 $ 60,382 $ 21,420 $ 37,354 $ 81,858 $ 183 Decrease, net (18,800) (6,651) (490) (2,502) (106) Balance as of June 30, 2024 $ 41,582 $ 14,769 $ 36,864 $ 79,356 $ 77 Amortization expense in connection with contract acquisition cost was approximately $4.8 million and $9.7 million for the three and six months ended June 30, 2024, respectively. Amortization expense in connection with contract acquisition cost was approximately $5.1 million and $13.4 million for the three and six months ended June 30, 2023, respectively. Accounts Receivable, Net Accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for credit losses is the Company’s estimate of the amount of probable credit losses in the Company’s existing accounts receivable, based on both specific and general reserves. The Company maintains general reserves on a collective basis by considering factors such as historical experience, creditworthiness, the age of the trade receivable balances, and current econom ic conditions. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company does not have any off-balance sheet credit exposure related to its customers. The activity in the allowance for credit losses is as follows: June 30, December 31, (In thousands) Balance, beginning of year $ 9,290 9,239 Additions charged to costs and expenses 8,928 3,319 Deductions/write-offs (8,862) (3,268) Balance, end of period $ 9,356 $ 9,290

Net Income (Loss) Per Share

Net Income (Loss) Per Share	6 Months Ended
	Jun. 30, 2024
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	Net Income (Loss) Per Share Basic income (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during the period. Diluted net income (loss) per share is computed by giving effect to all potentially dilutive common stock equivalents outstanding for the period. For purposes of this calculation, stock options, restricted stock units, warrants, 0.750% Convertible Senior Notes due 2024 (“2024 Notes”), and 0% Convertible Senior Notes due 2026 (the “2026 Notes”) are considered to be common stock equivalents but are excluded from the calculation of diluted net income (loss) per share when including them has an anti-dilutive effect. See Note 8 – Convertible Senior Notes, Net of Current Portion, Capped Call Transactions, and Warrants for additional information about the 2024 Notes, 2026 Notes and First Lien Convertible Senior Notes due 2029 (the “2029 Notes” and together with the 2024 Notes and the 2026 Notes, the “Notes”). Reconc iliation of shares used in calculating basic and diluted net income (loss) per share for the three and six months ended June 30, 2024 and 2023, is as follows: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (In thousands, except per share amounts) Numerator: Net income (loss) available to stockholders for basic net income per share $ 41,795 $ 10,822 $ 6,164 $ (6,598) Gain on debt extinguishment (73,083) — (73,083) — Interest on assumed conversion of convertible notes, net of tax — 136 — — Net (loss) income available to stockholders for diluted net income per share $ (31,288) $ 10,958 $ (66,919) $ (6,598) Denominator: Weighted-average shares used to compute basic net income (loss) per share 88,708,514 76,902,416 88,396,816 76,341,729 Weighted-average effect of dilutive securities: Stock options and employee stock purchase plan — 98,143 — — Restricted stock units — 166,156 — — Earn-outs — 5,575,251 — — Conversion option of the 2024 Notes — 1,878,810 — — Conversion option of the 2026 Notes 6,269,720 6,879,283 6,576,185 — Weighted-average shares used to compute diluted net (loss) income per share 94,978,234 91,500,059 94,973,001 76,341,729 Net income (loss) per share: Basic $ 0.47 $ 0.14 $ 0.07 $ (0.09) Diluted $ (0.33) $ 0.12 $ (0.70) $ (0.09) The securities listed below were excluded from the computation of diluted net income (loss) per share for the three and six months ended June 30, 2024 and for the six months ended June 30, 2023, as their effect would have been anti-dilutive. Further, the computation of diluted net income (loss) per share for the three months ended June 30, 2023 excluded approximately 3.8 million shares and 3.2 million shares related to stock options and RSUs, respectively, as their effect would have been anti-dilutive. As of June 30, 2024 2023 Shares subject to outstanding common stock options and employee stock purchase plan 2,880,837 3,541,432 Restricted stock units 8,907,079 3,738,894 Earn-outs — 5,575,251 Conversion option of the 2024 Notes 612,396 1,878,810 Conversion option of the 2026 Notes — 6,879,283 Warrants 9,746,723 — Total 22,147,035 21,613,670

Segment Information

Segment Information	6 Months Ended
	Jun. 30, 2024
Segment Reporting [Abstract]
Segment Information	Segment Information The Company accounts for its segment information in accordance with the provisions of ASC 280-10, “Segment Reporting.” ASC 280-10 establishes annual and interim reporting standards for operating segments of a company. ASC 280-10 requires disclosures of selected segment-related financial information about products, major customers, and geographic areas based on the Company’s internal accounting methods. T he chief operating decision maker (“CODM”), who is the Company’s Chief Executive Officer, evaluates performance, makes operating decisions, and allocates resources based on the financial information presented on a consolidated basis. Accordingly, management has determined that the Company operates as one operating and reportable segment. The Company was previously organized into two operating segments for purposes of making operating decisions and assessing performance: the Business segment and the Consumer segment. During the first quarter of 2023, the Consumer segment (consisting solely of the Kasamba business) was divested. As a result, the divestiture of Kasamba eliminated the Company’s Consumer segment. See Note 19 – Divestitures for additional information. Geographic Information The Company is domiciled in the United States and has international operations around the globe. The following table presents the Company’s long-lived assets by geographic region as of June 30, 2024 and December 31, 2023: June 30, December 31, 2024 2023 (In thousands) United States $ 412,660 $ 438,420 Germany 41,497 45,424 Australia 11,655 11,660 Netherlands 5,760 5,863 Other (1) 11,756 12,438 Total long-lived assets $ 483,328 $ 513,805 —————————————— (1) United Kingdom, Japan, France, Italy, Spain, Canada, and Singapore

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets, Net Goodwill Goodwill represents the excess of the aggregate purchase price over the fair value of net identifiable assets acquired in a business combination. Goodwill is not amortized, but is tested for impairment at the reporting unit level using either a qualitative or quantitative assessment on an annual basis, or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. In the valuation of goodwill, management must make assumptions regarding estimated future cash flows to be derived from the Company’s business. If these estimates or their related assumptions change in the future, the Company may be required to record impairment for these assets. The changes in the carrying amount of goodwill as of June 30, 2024 and December 31, 2023 are as follows: Consolidated (In thousands) Balance as of December 31, 2022 $ 296,214 Adjustments to goodwill: Goodwill impairment (1) (11,895) Foreign exchange adjustment 1,312 Balance as of December 31, 2023 $ 285,631 Adjustments to goodwill: Goodwill impairment (1) (3,627) Foreign exchange adjustment (1,278) Balance as of June 30, 2024 $ 280,726 —————————————— (1) The sum of these amounts represents the accumulated goodwill impairment balance in our operating segment as of June 30, 2024. As a result of the Company’s intention to sell or dispose of its WildHealth reporting unit, during the first quarter of 2024, the Company recorded a non-cash impairment charge of $3.6 million in the condensed consolidated statements of operations, to recognize a full impairment of goodwill associated with its WildHealth reporting unit. There were no impairments of goodwill in the Company’s Business reporting unit during the three and six months ended June 30, 2024. There were no impairments of goodwill during the three and six months ended June 30, 2023 . Intangible Assets, Net Intangible assets are summarized as follows: June 30, 2024 Gross Accumulated Net Carrying Amount Weighted (In thousands) (In years) Amortizing intangible assets: Technology $ 94,559 $ (67,998) $ 26,561 5.0 Customer relationships 32,060 (20,593) 11,467 10.0 Patents 16,497 (2,226) 14,271 13.6 Trademarks 1,404 (826) 578 5.0 Trade names 1,044 (1,044) — 2.8 Other 914 (835) 79 4.1 Total $ 146,478 $ (93,522) $ 52,956 December 31, 2023 Gross Accumulated Net Carrying Amount Weighted (In thousands) (In years) Amortizing intangible assets: Technology $ 94,549 $ (60,465) $ 34,084 5.0 Customer relationships 32,025 (19,542) 12,483 10.0 Patents 15,350 (1,916) 13,434 12.9 Trademarks 1,400 (707) 693 5.0 Trade names 1,044 (672) 372 2.8 Other 914 (355) 559 4.1 Total $ 145,282 $ (83,657) $ 61,625 Amortization expense is calculated over the estimated useful life of the asset. Aggregate amortization expense for intangible assets and finance leases, net was $3.7 million and $5.5 million for the three months ended June 30, 2024 and 2023, respectively, and $7.9 million and $10.9 million for the six months ended June 30, 2024 and 2023, respectively. Of these amounts, amortization expense included in cost of revenue in our condensed consolidated statements of operations was $3.0 million and $4.6 million for the three months ended June 30, 2024 and 2023, respectively, and $6.3 million and $9.1 million for the six months ended June 30, 2024 and 2023, respectively. As a result of our impairment test during the first quarter of 2024, the Company recognized an immaterial non-cash impairment charge of $2.2 million included in impairment of intangibles and other assets in the condensed consolidated statements of operations, related to intangible assets associated with its WildHealth reporting unit, due to a plan to sell or dispose of the WildHealth reporting unit, as discussed above. There were no impairments of intangible assets during the three and six months ended June 30, 2023. As of June 30, 2024, estimated annual amortization expense for the next five years and thereafter is as follows: Estimated Amortization Expense (In thousands) Remainder of 2024 $ 7,307 2025 14,205 2026 11,519 2027 1,411 2028 1,343 Thereafter 17,171 Total $ 52,956

Property and Equipment

Property and Equipment	6 Months Ended
	Jun. 30, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment, Net Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the related assets. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the asset. The Company reviews the estimated useful lives of its property and equipment on an ongoing basis. The following table presents the detail of property and equipment, net for the periods presented: June 30, December 31, Useful life (In thousands) (In years) Internal-use software development costs $ 183,169 $ 181,079 5 Computer equipment and software 126,181 123,580 3 to 5 Furniture, equipment and building improvements 328 327 The lesser of 5 or estimated useful life Finance lease right-of-use assets 238 3,060 2 Property and equipment, at cost 309,916 308,046 Less: accumulated depreciation (202,968) (188,721) Property and equipment, net $ 106,948 $ 119,325 Depreciation and amortization expense of property and equipment was $7.7 million and $9.7 million during the three months ended June 30, 2024 and 2023, respectively, and $15.9 million and $17.1 million during the six months ended June 30, 2024 and 2023, respectively. Expenditures for routine maintenance and repairs are charged to operating expense as incurred. Major renewals and improvements are capitalized and depreciated over their estimated useful lives. During the three months ended June 30, 2024, the Company recorded non-cash impairment charges of $8.3 million related to capitalized software development costs. The impairment charges were included in the condensed consolidated statements of operations for the three and six months ended June 30, 2024. These impairment charges pertained to internal projects that were discontinued and had no future economic benefit. There were no impairments of property and equipment during the three and six months ended June 30, 2023. Total depreciation included in our condensed consolidated statements of operations for the three and six months ended June 30, 2024 and 2023 is as follows: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (In thousands) (In thousands) Cost of revenue $ 1,771 $ 2,186 $ 3,453 $ 4,433 Sales and marketing 740 741 1,640 1,467 General and administrative 33 139 191 300 Product development 5,170 6,660 10,655 10,888 Total $ 7,714 $ 9,726 $ 15,939 $ 17,088

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	6 Months Ended
	Jun. 30, 2024
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	Accrued Expenses and Other Current Liabilities The following table presents the detail of accrued expenses and other current liabilities for the periods presented: June 30, December 31, (In thousands) Professional services and consulting and other vendor fees $ 48,150 $ 67,585 Payroll and other employee-related costs 10,521 20,767 Warrants liability 5,266 — Finance lease liability 108 3,037 Restructuring 1,344 2,076 Sales commissions 475 734 Non-income tax 556 556 Other 1,817 2,269 Total $ 68,237 $ 97,024

Convertible Senior Notes, Net o

Convertible Senior Notes, Net of Current Portion, Capped Call Transactions, and Warrants	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
Convertible Senior Notes, Net of Current Portion, Capped Call Transactions, and Warrants	Convertible Senior Notes, Net of Current Portion, Capped Call Transactions, and Warrants Convertible Senior Notes due 2024 and Capped Calls In March 2019, the Company issued $230.0 million aggregate principal amount of its 0.750% Convertible Senior Notes due 2024 in a private placement. Interest on the 2024 Notes was payable semi-annually in arrears on March 1 and September 1 of each year. The 2024 Notes matured on March 1, 2024, on which date the Company repaid in full the outstanding $72.5 million in aggregate principal amount of the 2024 Notes. On March 21, 2023, the Company entered into individual privately negotiated transactions (the “Note Repurchase Agreements”) with certain holders of its 2024 Notes, pursuant to which the Company agreed to pay an aggregate of approximately $149.7 million in cash for the repurchase of approximately $157.5 million in aggregate principal amount of the 2024 Notes (the “Note Repurchases”). D uring the first quarter of 2023, the Company recognized a $6.1 million gain, net of transaction costs of $0.5 million on debt extinguishment, which represented the difference between the carrying value and the fair value of the 2024 Notes just prior to the Note Repurchases, which was recorded in Other income, net in the condensed consolidated statements of operations. The gain on debt extinguishment was subsequently adjusted by an immaterial amount of $1.1 million with a total gain of $7.2 million reported as of December 31, 2023. Upon completion of the Note Repurchases, the aggregate principal amount of the 2024 Notes was reduced by $157.5 million to $72.5 million and the carrying amount of the 2024 Notes reduced by $228.3 million to $72.0 million. A corresponding portion of the 2024 capped calls were terminated in connection following the Note Repurchases as required by their terms for minimal consideration. As of June 30, 2024 , there was no outstanding principal amount of the 2024 Notes. Convertible Senior Notes due 2026 and Capped Calls In December 2020, the Company issued $517.5 million aggregate principal amount of its 2026 Notes in a private placement, of which $361.2 million aggregate principal amount was outstanding as of June 30, 2024 . The 2026 Notes are senior unsecured obligations of the Company. The 2026 Notes will mature on December 15, 2026, unless earlier repurchased or redeemed by the Company or converted pursuant to their terms. The total net proceeds from the offering of the 2026 Notes, after deducting debt issuance costs, was approximately $505.3 million. Each $1,000 in principal amount of the 2026 Notes is initially convertible into 13.2933 shares of the Company’s common stock par value $0.001, which is equivalent to an initial conversion price of approximately $75.23 per share. The conversion rate is subject to adjustment upon the occurrence of certain specified events but will not be adjusted for any accrued and unpaid special interest. In addition, following certain corporate events that occur prior to the maturity date, the Company will increase the conversion rate for a holder who elects to convert its 2026 Notes in connection with such a corporate event. The 2026 Notes are not redeemable prior to the maturity date of the 2026 Notes and no sinking fund is provided for the 2026 Notes. The indenture governing the 2026 Notes contains events of default customary for convertible notes issued in connection with similar transactions. If the Company undergoes a “fundamental change” (as defined in the indenture governing the 2026 Notes), which includes a change of control or the failure of the Company’s common stock to be listed or quoted on any of the Nasdaq Global Select Market, The Nasdaq Global Market or the New York Stock Exchange, holders may require the Company to repurchase for cash all or any portion of their 2026 Notes in principal amounts of $1,000 or a multiple thereof at a fundamental change repurchase price equal to 100% of the principal amount of the 2026 Notes to be repurchased, plus accrued and unpaid special interest to, but excluding, the fundamental change repurchase date. Holders of the 2026 Notes may convert their 2026 Notes at their option at any time prior to the close of business on the business day immediately preceding August 15, 2026, in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on March 31, 2021 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the 2026 Notes on each applicable trading day as determined by the Company; (2) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the indenture governing the 2026 Notes) per $1,000 principal amount of 2026 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate for the 2026 Notes on each such trading day; (3) with respect to any 2026 Notes that the Company calls for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events. On or after August 15, 2026, holders may convert all or any portion of their 2026 Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of its common stock or a combination of cash and shares of its common stock, at the Company’s election. During the three and six months ended June 30, 2024, the conditions allowing holders of the 2026 Notes to convert were not met. In connection with the offering of the 2026 Notes, the Company entered into privately-negotiated capped call option transactions with certain counterparties (the “2026 capped calls”). The 2026 capped calls each have an initial strike price of approximately $75.23 per share, subject to certain adjustments, which corresponds to the initial conversion price of the 2026 Notes. The 2026 capped calls have initial cap prices of $105.58 per share, subject to certain adjustment events. The 2026 capped calls cover, subject to anti-dilution adjustments, approximately 6.88 million shares of common stock. The 2026 capped calls are generally intended to reduce or offset the potential dilution to the common stock upon any conversion of the 2026 Notes with such reduction or offset, as the case may be, subject to a cap based on the cap price. The 2026 capped calls expire on December 15, 2026, subject to earlier exercise. The 2026 capped calls are subject to either adjustment or termination upon the occurrence of specified extraordinary events affecting the Company, including a merger event, a tender offer, and a nationalization, insolvency or delisting involving the Company. In addition, the 2026 capped calls are subject to certain specified additional disruption events that may give rise to a termination of the 2026 capped calls, including changes in law, failure to deliver, and hedging disruptions. The 2026 capped calls are recorded in stockholders’ equity and are not accounted for as derivatives. The net cost of $46.1 million incurred to purchase the 2026 capped calls was recorded as a reduction to additional paid-in capital in the accompanying condensed consolidated balance sheets. Pursuant to a privately negotiated exchange and purchase agreement (the “Exchange and Purchase Agreement”), on June 3, 2024, the Company exchanged $146.0 million principal amount of the 2026 Notes then held by an investor for $100.0 million principal amount of new 2029 Notes, and the same investor purchased an additional $50.0 million principal amount of the 2029 Notes for cash. In connection with the exchange and purchase, the Company also issued the Warrants (as defined below) to the investor, and the investor agreed to purchase up to $50.0 million of additional 2029 Notes upon the Company’s request at any time prior to December 3, 2024 (the “Delayed Draw Notes”). As a result of the exchange and purchase transactions, during the second quarter of 2024, the Company recognized a $68.1 million gain on debt extinguishment which represented the difference between the carrying value of the 2026 Notes so exchanged and the collective fair value of the 2029 Notes and the Warrants, net of the cash payment received from the investor. The extinguishment gain was recorded in Other income, net in the condensed consolidated statements of operations. On June 13, 2024, the Company repurchased $10.3 million principal amount of the 2026 Notes for $4.9 million in cash. As a result of the transaction, during the second quarter of 2024, the Company recognized a $5.0 million gain on debt extinguishment, which was recorded in Other income, net in the condensed consolidated statements of operations. As a result of the adoption of ASU 2020-06 “Debt - Debt with Conversion and Other Options (Subtopic 815-40) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), the 2026 Notes are accounted for as a single liability. The 2026 Notes were classified as long-term liabilities in the accompanying condensed consolidated balance sheets as of June 30, 2024. After the completion of the exchange and repurchase, the aggregate principal amount of the 2026 Notes was reduced by $156.3 million to $361.2 million and the carrying amount of the 2026 Notes reduced by $154.7 million to $357.8 million. A corresponding portion of the 2026 capped calls were terminated in connection following the transactions as required by their terms for no consideration. The remaining term over which the 2026 Notes’ debt issuance costs will be amortized is 2.4 years at an effective interest rate of 0.40% for the three months ended June 30, 2024 . First Lien Convertible Senior Notes due 2029 In June 2024, the Company issued $150.0 million aggregate principal amount of its 2029 Notes pursuant to the Exchange and Purchase Agreement including $100.0 million aggregate principal amount issued in exchange for $146.0 million aggregate principal amount of 2026 Notes and $50.0 million aggregate principal amount issued for cash. The Company paid third parties $7.6 million in connection with the transaction, which was capitalized as debt issuance costs. At the time of the exchange, the fair value of the 2029 Notes approximated $118.1 million, and the Company recognized a debt discount of $31.9 million. Unless earlier repurchased or redeemed by the Company or converted pursuant to their terms, the 2029 Notes will mature on the earlier of (a) June 15, 2029 and (b) 91 days before the maturity of the 2026 Notes, if greater than $60.0 million principal amount of 2026 Notes remains outstanding on such date. The amount payable by the Company if the 2029 Notes mature pursuant to clause (b) will be equal to 100% of the aggregate principal amount of the 2029 Notes, plus accrued and unpaid interest, plus the remaining future interest payments that would have been payable through June 15, 2029, discounted at a rate equal to the comparable treasury rate plus 50 basis points (the “Make-Whole Amount”). From June 3, 2024, until the earlier of the date of issuance of the Delayed Draw Notes and December 15, 2026, interest on the 2029 Notes will accrue at a rate of 10.83% (consisting of 4.17% cash and 6.66% paid in kind (“PIK”)) per annum. From the date of issuance of the Delayed Draw Notes and prior to December 15, 2026, interest on the 2029 Notes will increase and accrue at a rate of 11.375% (consisting of 4.375% cash and 7.00% PIK) per annum. On and after December 15, 2026, interest on the 2029 Notes will further increase and accrue at a rate of 13% (consisting of 5% cash and 8% PIK) per annum. The Company may, at its option, redeem the 2029 Notes, in whole or in part, prior to June 15, 2025 at a price equal to the Make-Whole Amount. On or after June 15, 2025, and prior to June 15, 2026, the Company may, at its option, redeem the 2029 Notes, in whole or in part for an amount of cash equal to the sum of (i) 106.50% of the aggregate principal amount of the 2029 Notes (including all increases to the principal amount as the result of previous payments of PIK interest) plus (ii) 106.50% of all accrued and unpaid PIK interest plus (iii) all accrued and unpaid cash interest. On or after June 15, 2026, and prior to December 15, 2026, the Company may, at its option, redeem the 2029 Notes, in whole or in part for an amount of cash equal to the sum of (i) 103.25% of the aggregate principal amount of the 2029 Notes (including all increases to the principal amount as the result of previous payments of PIK interest) plus (ii) 103.25% of all accrued and unpaid PIK interest plus (iii) all accrued and unpaid cash interest. From December 15, 2026 until maturity, the Company may, at its option, redeem the 2029 Notes, in whole or in part for an amount of cash equal to the sum of (i) 113% of the aggregate principal amount of the 2029 Notes (including all increases to the principal amount as the result of previous payments of PIK interest) plus (ii) 113% of all accrued and unpaid PIK interest plus (iii) all accrued and unpaid cash interest. In addition, the Make-Whole Amount will be payable in the event of an acceleration of the 2029 Notes or repurchase triggered by certain asset sales. No sinking fund is provided for the 2029 Notes. The 2029 Notes are guaranteed on a senior basis by certain of the Company’s direct and indirect domestic and foreign subsidiaries and secured by first priority security interests in substantially all of the assets of the Company and such subsidiary guarantors, subject to customary exceptions. The indenture governing the 2029 Notes contains affirmative and negative covenants and events of default customary for senior secured notes issued in connection with similar transactions. The negative covenants include limitations on asset sales, the incurrence of debt, preferred stock and liens, fundamental changes, investments, dividends and other payment restrictions affecting subsidiaries, restricted payments and transactions with affiliates. Among other things, these covenants generally prohibit the payment of cash dividends on the Company’s common stock. The indenture governing the 2029 Notes permits the Company and its subsidiaries to incur, subject to certain requirements, up to $150.0 million of debt that is junior in lien priority and subordinated in right of payment to the 2029 Notes. The indenture governing the 2029 Notes also includes a financial covenant that requires the Company at all times to maintain a minimum cash balance of $60.0 million (excluding proceeds of the 2029 Notes). Upon request of the investor, the indenture governing the 2029 Notes requires the Company to enter into a registration rights agreement with respect to the 2029 Notes containing customary terms including demand, shelf and piggyback registration rights. If the Company undergoes a “fundamental change” (as defined in the indenture governing the 2029 Notes), which includes a change of control or the failure of the Company’s common stock to be listed or quoted on any of the Nasdaq Global Select Market, The Nasdaq Global Market or the New York Stock Exchange, holders may require the Company to repurchase all or any portion of their 2029 Notes at a repurchase price equal to 100% of the aggregate principal amount of the 2029 Notes to be repurchased, plus accrued and unpaid interest, plus an amount equal to 66% of the remaining future interest payments (including PIK interest) that would have been payable through June 15, 2029, discounted at a rate equal to the comparable treasury rate plus 50 basis points. Holders of the 2029 Notes may convert their 2029 Notes at their option at any time prior to the close of business on the business day immediately preceding February 15, 2029 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on September 30, 2024 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the 2029 Notes on each applicable trading day as determined by the Company; (2) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the indenture governing the 2029 Notes) per $1,000 principal amount of 2029 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the product of (x) the quotient of (i) the “conversion amount” (as defined in the Indenture) in respect of $1,000 principal amount of the 2029 Notes on such trading day divided by (ii) 1,000 times (y) the conversion rate for the 2029 Notes on each such trading day; (3) with respect to any 2029 Notes that the Company calls for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; (4) upon the occurrence of specified corporate events; or (5) during the period from August 17, 2026 through September 14, 2026, if the aggregate principal amount of 2026 Notes exceeds $60.0 million on August 16, 2026. On or after February 15, 2029, holders may convert all or any portion of their 2029 Notes at any time prior to the close of business on June 13, 2029, regardless of the foregoing circumstances. Our 2029 Notes include certain embedded features requiring bifurcation, which did not have material values as of June 30, 2024 due to management’s estimates of the likelihood of triggering events, but that may have value in the future should those estimates change, with any change in fair value recorded in the Company’s condensed consolidated statements of operations. The 2029 Notes (including all accrued and unpaid interest) are convertible at the option of the holders at certain times into cash based on a daily conversion value calculated on a proportionate basis for each trading day in a 50 trading day observation period, initially corresponding to 13.2933 shares of the Company’s common stock per $1,000 principal amount of 2029 Notes. The Company is not required to deliver its common stock upon conversion under any circumstances. The conversion rate for the 2029 Notes is subject to adjustment if certain events occur and contains customary anti-dilution protections. During the three months ended June 30, 2024 , the conditions allowing holders of the 2029 Notes to convert were not met. As a result of the adoption of ASU 2020-06, the 2029 Notes are accounted for as a single liability, and the carrying amount of the 2029 N otes is $110.9 million as of June 30, 2024, consisting of principal of $150.0 million, net of unamortized issuance costs of $7.5 million and debt discount of $31.6 million . The 2029 Notes were classified as long-term liabilities in the accompanying condensed consolidated balance sheets as of June 30, 2024. The remaining term over which the 2029 Notes’ debt issuance costs will be amortized is 5.0 years at an effective interest rate of 19.18% for the six months ended June 30, 2024. Unamortized debt issuance costs incurred in connection with securing the Company’s financing arrangements are presented in the condensed consolidated balance sheets as a direct deduction from the carrying amount of the outstanding borrowings, consistent with debt discounts. All deferred financing costs are amortized to interest expense. The net carrying amount of the Notes as of June 30, 2024 and December 31, 2023 is as follows: June 30, 2024 December 31, 2023 2026 Notes 2029 Notes Total 2024 Notes 2026 Notes Total (In thousands) (In thousands) Principal $ 361,204 $ 150,000 $ 511,204 $ 72,492 $ 517,500 $ 589,992 Unamortized debt discount — (31,578) (31,578) — — — Unamortized issuance costs (3,472) (7,488) (10,960) (99) (5,935) (6,034) Total net carrying value $ 357,732 $ 110,934 $ 468,666 $ 72,393 $ 511,565 $ 583,958 Less: short-term debt, net — — — 72,393 — 72,393 Long-term debt, net $ 357,732 $ 110,934 $ 468,666 $ — $ 511,565 $ 511,565 The following table sets forth the interest expense recognized related to the Notes: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (In thousands) (In thousands) Contractual interest expense $ 1,591 $ 128 $ 1,681 $ 569 Amortization of debt discount 301 — 301 — Amortization of debt issuance costs 531 1,807 1,042 2,727 Total interest expense $ 2,423 $ 1,935 $ 3,024 $ 3,296 Interest expense of $2.4 million and $3.0 million is reflected as a component of interest (expense) income, net in the accompanying condensed consolidated statements of operations for the three and six months ended June 30, 2024, respectively. Interest expense was $1.9 million and $3.3 million for the three and six months ended June 30, 2023, respectively. Warrants On June 3, 2024, pursuant to the Exchange and Purchase Agreement, the Company issued to the investor 10-year warrants with a strike price of $0.75 per share, exercisable for 9,746,723 shares of the Company’s common stock (the “Share-Settled Warrants”) and 10-year warrants with a strike price of $0.75 per share, exercisable with respect to a notional amount of 2,344,775 shares of the Company’s common stock for cash payments equal to the excess of “fair market value” (as defined therein) per share over the strike price, fully diluted subject to certain adjustments (the “Cash-Settled Warrants,” and collectively with the Share-Settled Warrants, the “Warrants.”). The Cash-Settled Warrants will permit the Company, subject to certain conditions (including to the extent that the Company, following payment, would have “available cash” (as defined therein) of less than $100.0 million ), to defer payment of the settlement amount at an annualized interest rate of 6.0% , compounded monthly. Warrants outstanding at the 10-year expiration will be exercised automatically (and in the case of the Share-Settled Warrants, will be exercised on a cashless basis) if, immediately prior to the expiration, the Fair Market Value per share is greater than the strike price. The Warrants contain customary anti-dilution protections and a beneficial ownership limitation on the investor’s ownership of the Company’s common stock, on a post-exercise basis (aggregating all securities convertible into or exercisable for the Company’s common stock), of 4.99% , subject to increase upon 61 days’ notice by the investor, but not to exceed 9.99% . The Warrants were classified as current liabilities in the Company’s condensed consolidated balance sheets as of June 30, 2024 and recorded at fair value of $5.3 million at the issuance date with any subsequent changes in fair value to be recorded in the Company’s condensed consolidated statements of operations.

Leases

Leases	6 Months Ended
	Jun. 30, 2024
Leases [Abstract]
Leases	Leases The Company has non-cancelable operating and finance leases for its corporate offices and other service agreements. Its leases have remaining lease terms of less than one The Company continues to actively assess its global lease portfolio. However, any additional de-recognition of ROU assets and incurrence of various one-time expenses in connection with early termination of additional leases are not expected to be material to its financial condition or results of operations. Supplemental cash flow information related to leases for the three and six months ended June 30, 2024 and 2023 is as follows: Three Months Ended Six Months Ended June 30, June 30, 2024 2023 2024 2023 (In thousands) (In thousands) Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 579 $ 863 $ 1,421 $ 1,837 Operating cash flows for finance leases 3 13 21 37 Financing cash flows for finance leases 26 968 353 1,926 The components of lease costs for the three and six months ended June 30, 2024 and 2023 are as follows: Three Months Ended Six Months Ended June 30, June 30, 2024 2023 2024 2023 (In thousands) (In thousands) Finance lease cost Amortization of right-of-use assets $ 21 $ 919 $ 355 $ 1,830 Interest 3 13 21 37 Operating lease cost 2,565 2,887 5,467 5,627 Total lease cost $ 2,589 $ 3,819 $ 5,843 $ 7,494 June 30, June 30, Weighted Average Remaining Lease Term: Operating leases 0.6 years 2.1 years Finance leases 1.3 years 1.1 years Weighted Average Discount Rate: Operating leases 7 % 7 % Finance leases 7 % 4 % Supplemental balance sheet information related to leases is as follows: Financial Statement Classification June 30, December 31, (In thousands) Assets Operating right-of-use assets Operating lease right-of-use assets $ 260 $ 4,135 Finance right-of-use assets Property and equipment, net 128 3,060 Liabilities Current liabilities: Operating lease liabilities Operating lease liabilities $ 268 $ 2,719 Finance lease liabilities Accrued expenses and other current liabilities 108 3,037 Non-current liabilities: Operating lease liabilities Operating lease liabilities, net of current portion — 2,173 Finance lease liabilities Other liabilities 28 85

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company measures its cash equivalents at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value: • Level 1: Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. • Level 2: Inputs reflect: quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means. • Level 3: Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available. Financial Assets and Liabilities The carrying amount of cash, accounts receivable, and accounts payable approximate their fair value due to their short-term nature. The Company’s assets and liabilities that are measured at fair value on a recurring basis, by level, within the fair value hierarchy as of June 30, 2024 and December 31, 2023, are summarized as follows: June 30, 2024 Level 1 Level 2 Level 3 Total (In thousands) Assets Cash equivalents: Money market funds $ 122,884 $ — $ — $ 122,884 Total assets $ 122,884 $ — $ — $ 122,884 Liabilities Warrants liability $ — $ — $ 5,266 $ 5,266 Total liabilities $ — $ — $ 5,266 $ 5,266 December 31, 2023 Level 1 Level 2 Level 3 Total (In thousands) Assets Cash equivalents: Money market funds $ 174,701 $ — $ — $ 174,701 Total assets $ 174,701 $ — $ — $ 174,701 In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value. Observable or market inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s assumptions based on the best information available. The Company’s money market funds are measure d at fair value on a recurring basis based on quoted market prices in active markets and are classified as Level 1 within the fair value hierarchy. The Company’s warrants and contingent earn-out liability were measured at fair value on a recurring basis and was classified as Level 3 within the fair value hierarchy. For 2023, the fair value was based on the negotiated contracts with the selling shareholders. Significant changes in unobservable inputs could result in significantly lower or higher fair value measurements. On a nonrecurring basis, the Company uses fair value measures when analyzing asset impairment. Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If it is determined such indicators are present and the review indicates that the assets will not be fully recoverable, based on undiscounted estimated cash flows over the remaining amortization periods, their carrying values are reduced to estimated fair value. The Company uses an income approach and inputs that constitute Level 3. The estimated fair value of outstanding balances of our Notes as of June 30, 2024 and December 31, 2023 are as follows: Level of Hierarchy Fair Value Principal Balance Unamortized Debt Discount Unamortized Debt Issuance Costs Net Carrying Value (In thousands) June 30, 2024 2026 Notes 2 $ 170,516 $ 361,204 $ — $ (3,472) $ 357,732 2029 Notes 2 118,122 150,000 (31,578) (7,488) 110,934 December 31, 2023 2024 Notes 2 $ 71,396 $ 72,492 $ — $ (99) $ 72,393 2026 Notes 2 364,487 517,500 — (5,935) 511,565 Management determines the fair value by using Level 2 inputs base d on observable market prices and antithetic variable technique don e by an independent valuation specia list. Warrants The Company recorded the fair value of the Warrants upon issuance using the Black-Scholes valuation model and is required to revalue these warrants at each reporting date with any changes in fair value recorded on the Company’s condensed statement of operations. The valuation of the Warrants was classified as Level 3 within the fair value hierarchy and influenced by the fair value of the underlying, or notional amount of, common stock of the Company. A summary of the Black-Scholes pricing model assumptions used to record the fair value of the Warrants as of June 30, 2024 is as follows: Stock price $ 0.62 Risk free rate 4.41 % Expected life (in years) 10 years Expected volatility 60 % Any significant changes in the inputs may result in significantly higher or lower fair value measurements. Refer to Note 8 – Convertible Senior Notes, Net of Current Portion, Capped Call Transactions, and Warrants for additional information. The changes in fair value of the Level 3 warrants and earn-out liabilities during the six months ended June 30, 2024 and the year ended December 31, 2023 are as follows: June 30, December 31, Balance, beginning of year $ — $ 72,221 Change in fair value of contingent consideration — 4,629 Change in fair value of liability awards — (27,857) Payments — (48,993) Issuance of warrants 5,266 — Balance, end of period $ 5,266 $ — Certain former stakeholders of the Company’s acquisitions were eligible to receive additional cash or share considerations based on the attainment of certain operating metrics in the periods subsequent to the acquisitions. These earn-out arrangements were accounted for as either contingent considerations arrangements or compensation arrangements. Contingent considerations were fair valued using significant inputs that are not observable in the market. The earn-outs determined to be compensatory were remeasured each reporting period based on whether the performance targets were probable of being achieved and recognized over the related service periods. During the year ended December 31, 2023, the Company settled the VoiceBase, Tenfold and e-Bot7 and WildHealth, Inc. earn-outs for approximately $19.9 million, $9.3 million, $7.7 million, and $12.0 million, respectively. Changes to the fair value of the earnouts were recognized as a component of stock-based compensation expense and Other income, net in the accompanying condensed consolidated statements of operations. Payments in cash were recognized as a component of compensation expense and payments in stock were recognized as a component of equity in the accompanying condensed consolidated statements of operations. There were no outstanding earnout liabilities as of June 30, 2024 based on settlements that were completed as of December 31, 2023.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Employee Benefit Plans The Company has a 401(k) defined contribution plan covering all eligible employees. The Company’s 401(k) policy is a Safe Harbor Plan, whereby the Company matches 100% of the first 3% of eligible compensation and 50% of the next 2% of eligible compensation. Furthermore, the match is immediately vested. Salaries and related expenses include $0.7 million and $0.9 million of employer matching contributions for the three months ended June 30, 2024 and 2023, respectively, and $1.8 million and $2.3 million for the six months ended June 30, 2024 and 2023, respectively. Letters of Credit As of June 30, 2024, the Company had letters of credit totaling $0.5 million outstanding as a security deposit for the due performance by the Company of the terms and conditions of a supply contract. Contractual obligations The Company’s purchase obligations consist of agreements to purchase goods and services entered into in the ordinary course of business. These purchase obligation agreements are primarily related to contracts with vendors in connection with Information Technology (“IT”) infrastructure and cloud computing-related services with remaining terms of two years or less. Our contractual obligations as of June 30, 2024, did not materially change from the amounts disclosed in our 2023 Annual Report on Form 10-K. Indemnifications The Company enters into service and license agreements in its ordinary course of business. Pursuant to some of these agreements, the Company agrees to indemnify certain customers from and against certain types of claims and losses suffered or incurred by them as a result of using the Company’s products. The Company also has agreements whereby its executive officers and directors are indemnified for certain events or occurrences while the officer or director is, or was, serving at the Company’s request in such capacity. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has a directors and officers insurance policy that reduces its exposure and enables the Company to recover a portion of any future amounts paid subject to customary deductibles. As a result of its insurance policy coverage, the Company believes the estimated fair value of these indemnification agreements is minimal. The Company has no liabilities recorded for these agreements as of the three and six months ended June 30, 2024 and 2023.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]
Stockholders' Equity	Stockholders’ Equity Stock-Based Compensation The Company’s stock-based compensation generally includes stock options, restricted stock units (“RSUs”), performance-vesting restricted stock units (“PRSUs”), and purchases under the Company’s 2019 Employee Stock Purchase Plan. Stock-based compensation expense related to RSUs is based on the market value of the underlying stock on the date of grant and the related expense is recognized ratably over the requisite service period. The stock-based compensation expense related to PRSUs is estimated at the grant date based on the expectation that performance goals will be achieved at the stated target level. The amount of compensation cost recognized depends on the relative satisfaction of the performance condition based on performance to date. Stock Incentive Plan The Company’s 2019 Stock Incentive Plan became effective on April 11, 2019. The 2019 Stock Incentive Plan, as amended and restated, allows the Company’s employees and directors to participate in the Company’s future performance through grants of stock-based awards of stock options and RSUs at the discretion of the board of directors. The number of shares authorized for issuance under the 2019 Stock Incentive Plan as of June 30, 2024 was 42,367,744 shares in the aggregate. Stock options granted under the 2019 Stock Incentive Plan have ten-year terms. As of June 30, 2024, 2,260,544 shares of common stock remained available for issuance (taking into account all stock option exercises and other equity award settlements through June 30, 2024). Employee Stock Purchase Plan As of June 30, 2024, there were 2,000,000 shares authorized and reserved for issuance under the Company’s ESPP, and as of June 30, 2024, 864,180 shares of common stock remained available for issuance under the ESPP (taking into account all share purchases through June 30, 2024). Inducement Plan There are 13,079,009 shares of common stock authorized and reserved for issuance under the Company’s 2018 Inducement Plan, inclusive of 6,920,000 shares, in the aggregate, authorized for issuance during the first and second quarters of 2024. As of June 30, 2024, 648,450 shares of common stock remained available for issuance under the Inducement Plan (taking into account all option exercises and other equity award settlements through June 30, 2024). CEO Inducement Award As part of an equity compensation package negotiated to induce John Sabino, the Company’s Chief Executive Officer, to accept employment with the Company, pursuant to the terms of the employment agreement entered into between Mr. Sabino and the Company, the Company granted Mr. Sabino an option to purchase 1,000,000 shares of common stock (the “CEO Inducement Award”) that will vest upon the satisfaction of certain performance-based and time-based vesting conditions. On May 17, 2024, the Company’s board of directors authorized 1,000,000 shares for issuance under the CEO Inducement Award in compliance with and in reliance on Nasdaq Listing Rule 5635(c)(4). The CEO Inducement Award was a standalone award granted outside of the 2019 Stock Incentive Plan and 2018 Inducement Plan. As of June 30, 2024, no shares of common stock remained available for issuance under the CEO Inducement Award. Stock Option Activity The following table is a summary of the Company’s stock option activity for the six months ended June 30, 2024: Stock Option Activity Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Options Weighted (In thousands) (Per option) (In years) (In thousands) Balance outstanding as of December 31, 2023 3,137 $ 22.68 4.84 $ 40 Granted 1,000 (1) 1.02 Cancelled or expired (1,256) 22.22 Balance outstanding as of June 30, 2024 2,881 15.38 6.3 1 Options vested and expected to vest 624 6.89 9.29 — Options exercisable as of June 30, 2024 1,692 $ 22.51 4.12 $ 1 —————————————— (1) Represents the CEO Inducement Award, which does not count against the number of shares reserved for issuance under the Company’s 2019 Stock Incentive Plan or the Company’s 2018 Inducement Plan. As of June 30, 2024, there was approximately $2.2 million of total unrecognized compensation cost related to non-vested share-based compensation arrangements. That cost is expected to be recognized over a weighted average period of approximately 1.7 years. Restricted Stock Unit and Performance-Vesting Restricted Stock Unit Activity The following table is a summary of the Company’s RSU and PRSU activity for the six months ended June 30, 2024: Number of Shares Weighted Average Grant Date Fair Value Aggregate Fair Value (In thousands) (Per share) (In thousands) Balance outstanding as of December 31, 2023 5,064 $ 12.53 $ 19,193 Awarded 5,699 0.99 Vested (969) 16.66 Forfeited (887) 15.82 Non-vested and outstanding as of June 30, 2024 8,907 4.37 5,171 Expected to vest 6,215 $ 4.66 $ 3,608 RSUs granted to employees generally vest over a three PRSUs granted are generally subject to both a service-based vesting condition and a performance-based vesting condition. PRSUs will vest upon the achievement of specifi ed performance targets and subject to continued service through the applicable vesting dates. The associated compensation cost is recognized over the requisite service period when it is probable that the performance condition will be satisfied. There were no PRSUs granted during the three and six months ended June 30, 2024 . PRSUs granted during the three and six months ended June 30, 2023, were immaterial. Total stock-based compensation costs included in our condensed consolidated statements of operations for the three and six months ended June 30, 2024 and 2023 are as follows: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (In thousands) (In thousands) Cost of revenue $ 288 $ (1,232) $ 631 $ 803 Sales and marketing 1,854 2,299 4,309 4,703 General and administrative 2,318 (13,882) 4,116 (11,250) Product development 1,440 (5,333) 4,402 (1,072) Total $ 5,900 $ (18,148) $ 13,458 $ (6,816)

Restructuring

Restructuring	6 Months Ended
	Jun. 30, 2024
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring LivePerson maintains restructuring initiatives to realign the Company’s cost structure to better reflect significant product and business model innovation and then-recent changes due to acquisitions and factors outside the control of the Company. As part of the restructuring initiative that commenced in the second quarter of 2022, the Company reoriented its global product and engineering organization for greater efficiency and focus, and reallocated some spending to increase its investment in customer success and go-to-market initiatives. In 2023, due to the changing technology landscape related to the evolution of LLMs, we were able to identify opportunities for significant cost savings because the latest generation of LLMs is able to build a bot in minutes, enabling reduction of headcount previously devoted to bot-building. Additionally, we have moved to a product-led growth structure where we flattened the organization to align to more efficient sales and service support ratios. In connection with the restructuring initiatives, the Company recognized restructuring costs of $3.1 million and $2.4 million during the three months ended June 30, 2024 and 2023, respectively, and $6.4 million and $13.9 million during the six months ended June 30, 2024 and 2023, respectively, which is included in restructuring costs in the accompanying condensed consolidated statements of operations. Such costs primarily include severance and other compensation costs as well as IT infrastructure contract termination costs. The following table presents the detail of the liability for the Company’s restructuring charges, which is included within Accrued expenses and other current liabilities within the accompanying condensed consolidated balance sheets as of June 30, 2024 and December 31, 2023: June 30, December 31, (In thousands) Balance, beginning of the year $ 2,076 $ 803 IT contract termination (reversals) costs (568) 5,744 Severance and other compensation associated costs 6,996 16,920 Cash payments (7,160) (21,391) Balance, end of period $ 1,344 $ 2,076 The Company anticipates that payments associated with the employee severance and other compensation associated costs reflected in the table above will be substantially completed by December 31, 2024. The following table presents the detail of expenses for the Company’s restructuring charges for the three months and six months ended June 30, 2024 and 2023: Three Months Ended Six Months Ended June 30, June 30, 2024 2023 2024 2023 (In thousands) (In thousands) IT contract termination reversals $ (1,284) $ — $ (568) $ — Severance and other associated costs 4,403 2,387 6,996 13,902 Total restructuring costs $ 3,119 $ 2,387 $ 6,428 $ 13,902

Legal Matters

Legal Matters	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Legal Matters	Legal Matters Stockholder Litigation In December 2023, a putative stockholder class action entitled Damri v. LivePerson, Inc., No. 1:23-cv-10517, was filed under the federal securities laws against the Company, its former Chief Executive Officer, and its Chief Financial Officer in the United States District Court for the Southern District of New York. The complaint alleges that the Company’s Form 10-Q filings and forecasts for the first, second, and third quarters of fiscal year 2022 were false and misleading in violation of Section 10(b) of the Securities Exchange Act of 1934, based on the Company’s later disclosures and report on Form 10-K on March 16, 2023. On May 31, 2024, the plaintiff filed an amended complaint. The Company moved to dismiss the amended complaint on August 1, 2024. A parallel litigation on behalf of stockholders who purchased their shares on the Tel Aviv Stock Exchange, entitled Weissbrod v. LivePerson, Inc., is pending in the Tel Aviv District Court in Israel, but has been stayed pending further developments in the Damri case. In January 2024, a purported derivative action entitled Marti v. LoCascio, No. 1:24-cv-00598, was filed in the United States District Court for the Southern District of New York by a purported stockholder of the Company against the Company’s former Chief Executive Officer, its Chief Financial Officer, most of the members of the current board of directors and several former directors. The Marti litigation claims that the Company itself was harmed by the same acts and omissions underlying the Damri federal securities lawsuit, and seeks to recover unspecified losses on behalf of the Company. The Marti case is stayed pending further developments in the Damri case. In June and July 2024, three other purported derivative actions were filed by purported stockholders of the Company against the Company’s former Chief Executive Officer, its Chief Financial Officer, most of the members of the current board of directors and several former directors. These three purported derivative actions, similar to the Marti litigation, claim that the Company itself was harmed by the same acts and omissions underlying the Damri federal securities lawsuit, and seek to recover unspecified losses on behalf of the Company. The three actions are entitled: (i) Steffens v. Block, No. 1:24-cv-04481, filed in the United States District Court for the Southern District of New York; (ii) Ravi v. LoCascio, Index No. 653498/2024, filed in the Supreme Court of the State of New York, New York County, and (iii) Morales v. LoCascio, No. 1:24-cv-05297, filed in the United States District Court for the Southern District of New York. I n January 2024, a purported stockholder of the Company filed a lawsuit against the Company and its Board of Directors entitled Browne v. Layfield, No. 2024-0079, in the Court of Chancery of the State of Delaware. The complaint asserted a claim for breach of fiduciary duty based upon a Tax Benefits Preservation Plan. In February 2024, the Board approved technical amendments to the Tax Benefits Preservation Plan which were filed by the Company on Form 8-K, and the case was dismissed as moot, subject to attorneys’ fees on behalf of the plaintiff. The plaintiff has sought $0.9 million in fees and expenses, which the Company has opposed. In February 2024, Starboard Value LP and several of its related entities and investment funds filed a lawsuit against the Company, its former Chief Executive Officer and its Chief Financial Officer entitled Starboard Value LP v. LivePerson, Inc., No. 2024-0103, in the Court of Chancery of the State of Delaware. The complaint alleges common law fraud, fraudulent inducement and negligent misrepresentation in connection with an alleged scheme to induce Starboard to settle its 2022 proxy contest against the Company and, as stated in the complaint, involves previous Starboard allegations of misrepresentations in the Company’s public disclosures that the Company previously informed Starboard were found to be unsubstantiated following an independent investigation. The complaint seeks unspecified damages. The defendants have filed an answer denying the substantive allegations of the complaint. COVID-Related Matters As has been widely reported, there is heightened scrutiny by the federal government across many programs related to global novel coronavirus disease (“COVID-19”) that were introduced during the COVID-19 pandemic. The Company previously provided products and services related to COVID-19 testing and accompanying software. Those products and services have been the subject of inquiry and review by Medicare, the Department of Justice and the U.S. Food and Drug Administration. The Company has discontinued all products and services related to COVID-19, and has responded to and intends to continue to cooperate with governmental inquiries related to its previous engagement in COVID-19 related product and service offerings. Other Legal, Administrative, Governmental and Regulatory Matters From time to time, the Company is or may be subject to or involved in legal, administrative, governmental and/or regulatory proceedings, inquiries and investigations as well as actual or threatened litigation, claims and/or demands (each an “Action” and collectively “Actions”). These have included and may include (without limitation) Actions brought by or against the Company, its affiliates, subsidiaries, directors and/or officers with respect to intellectual property, contracts, financial, commercial, employment, legal, compliance, privacy, data security, regulatory and/or other matters related to our business, as well as Actions brought against the Company’s customers for which the Company has a contractual indemnification obligation. Regardless of the outcome, Actions can have an adverse impact on the Company because of defense and/or settlement costs, diversion of management resources, reputational risks and other factors. Accruals The Company accrues for certain contingencies when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated and discloses certain contingencies for which no accrual has been made as appropriate and in compliance with ASC 450, “Contingencies”. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. The accruals or estimates, if any, resulting from the foregoing analysis, are reviewed at least quarterly and adjusted to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular matter.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Income taxes are accounted for under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences are expected to become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. The Company records both the interest accrued on the underpayment of income taxes and penalties, if any, related to unrecognized tax benefits in the provision for (benefit from) income taxes in its condensed consolidated statements of operations. The Company maintains a valuation allowance against its U.S., e-bot7 Germany and Bulgaria deferred tax assets as it considered its cumulative losses in recent years as a significant piece of negative evidence. Since valuation allowances are evaluated by jurisdiction, the Company believes that the deferred tax assets related to LivePerson Australia Pty. Ltd., Engage Pty. Ltd., LivePerson (UK) Ltd., LivePerson Italy, LivePerson Japan, and LivePerson Ltd. (Israel) are more likely than not to be realized as these jurisdictions have positive cumulative pre-tax book income after adjusting for permanent and one-time items. During the year ended December 31, 2023, there was an increase in the valuation allowance recorded of $23.7 million. The Company recorded a tax provision o f $1.3 million and $1.6 million for the three and six months ended June 30, 2024 , respectively, which consists of a tax provision on operating earnings of non-US subsidiaries and interest accrual on unrecognized tax benefits in Israel. The Company recorded a benefit from income taxes of $0.2 million and a tax provision of $1.1 million for the three and six months ended June 30, 2023 , respectively, which was made up of tax provision on operating earnings, a stock compensation tax deficiency related to the stock compensation arrangements of LivePerson, Inc., LivePerson (UK) Ltd., and LivePerson Ltd. (Israel), and an increase in valuation allowance activity on deferred tax assets resulting from a release of deferred tax liabilities as a result of the Kasamba sale during the first quarter of 2023. The increase in the tax provision for the three and six months ended June 30, 2024 as compared to the three and six months ended June 30, 2023 is due to changes in the forecasted earnings by jurisdiction year over year, the effects of U.S. state taxes as a result of net operating loss utilization limitations, and offsetting activities related to the prior period tax benefit including the change in Israeli tax rate, the return-to-provision adjustments from foreign tax return filings, and the changes in valuation allowance connected to the sale of Kasamba during the prior period. The Company had a valuation allowance on certain deferred tax assets for the year ended December 31, 2023 of $211.2 million. In 2024, the Company expects an estimated increase in the valuation allowance of $15.4 million, al l of which would be recorded as an expense. During 2023, an increase in the valuation allowance in the amount of $23.7 million was recorded as an expense.

Equity Method Investments

Equity Method Investments	6 Months Ended
	Jun. 30, 2024
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investments	Equity Method Investment On February 13, 2022, the Company and Pasaca Capital Inc. (“Pasaca”) entered into a joint venture agreement (the “JV Agreement”) to form Claire Holdings, Inc. (“Claire”), a joint venture to build, create, and administer a marketplace for health and well-being diagnostic testing. Pursuant to the terms of the JV Agreement, the Company agreed to contribute a total of $19.0 million over a five-year period in exchange for a 19.2% ownership interest in Claire. Pasaca agreed to contribute $80.0 million to Claire over a five-year period in exchange for an 80.8% ownership interest in Claire. The Company accounts for its 19.2% interest in Claire using the equity method of accounting. The Company recorded its ownership percentage of losses of Claire in other income, net in the amount of $0.8 million and $1.8 million for the three and six months ended June 30, 2023, respectively. The Company’s equity method investment in joint venture was reduced to zero during the prior year, based on the prior year losses, and remained at zero on the accompanying condensed consolidated balance sheet as of June 30, 2024. Refer to Note 18 – Related Parties for additional information.

Variable Interest Entity

Variable Interest Entity	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	Variable Interest Entities The Company prepares its condensed consolidated financial statements in accordance with ASC 810, “Consolidation”, which provides for the consolidation of variable interest entities (“VIEs”) of which the Company is the primary beneficiary. In February 2022, the Company acquired WildHealth as well as certain variable interests that WildHealth has in four Professional Corporations (“PCs”). The PCs are owned by a medical practitioner in accordance with certain state laws which restrict the corporate practice of medicine and require medical practitioners to own such entities. WildHealth provides management and other services to the PCs in exchange for a management fee and provides financial support to the PCs through a revolving credit arrangement. WildHealth also has separate agreements with the equity holder of the PCs where it may acquire and assign such equity interests for certain PCs. The agreement entitles WildHealth to control rights sufficient to require the Company to consolidate the balance sheet and results of operations of the PCs as VIEs. The Company determined that the PCs were VIEs as WildHealth was the primary beneficiary of the PCs. The assets, liabilities, revenues, and operating results of the VIEs after elimination of intercompany transactions were not material as of and for the three and six months ended June 30, 2024. In the second quarter of 2024, the Company entered into an agreement for and completed the sale of 100% equity in WildHealth. As a result, as of June 30, 2024, the PCs related to WildHealth are no longer considered VIEs of the Company. Refer to Note 19 - Divestitures for additional information.

Related Parties

Related Parties	6 Months Ended
	Jun. 30, 2024
Related Party Transactions [Abstract]
Related Parties	Related Parties Related parties are defined as entities related to the Company’s directors or main sha reholders as well as equity method affiliates. During the year ended December 31, 2023, the Company provided services to Claire, an equity method affiliate (refer to Note 16 – Equity Method Investment for additional information on the equity method affiliate) in exchange for fees through certain commercial arrangements. These arrangements facilitated Claire’s build out and operations.

Divestiture

Divestiture	6 Months Ended
	Jun. 30, 2024
Equity Method Investments and Joint Ventures [Abstract]
Divestiture	Divestitures Fiscal 2024 Divestitures In the first quarter of 2024, the Company announced its intent to sell or dispose of WildHealth. As of March 31, 2024, the goodwill and intangible assets associated with the WildHealth reporting unit were fully impaired. See Note 5 – Goodwill and Intangible Assets, Net for additional details. In the second quarter of 2024, the Company entered into an agreement for and completed the sale of 100% equity in WildHealth with a third party. Pursuant to ASC Subtopic 205-20, Presentation of Financial Statements - Discontinued Operations , the divestiture did not meet the criteria for presentation as a discontinued operation. WildHealth was part of the Business segment and was a separate reporting unit. The transaction resulted in a loss of $0.6 million which was recognized and presented separately in Loss (gain) on divestiture on the Company’s condensed consolidated statements of operations for the three months ended June 30, 2024. Subsequent to the closing, the Company does not have ongoing involvement or arrangements with WildHealth. Fiscal 2023 Divestitures In the fourth quarter of 2022, the Company entered into a non-binding Letter of Intent to divest Kasamba, Inc. and Kasamba LTD (together “Kasamba”), which represented the Company’s Consumer segment. Pursuant to ASC Subtopic 360-10, Impairment or Disposal of Long-Lived Assets , t he Company applied held for sale accounting treatment to the assets and liabilities of Kasamba. Accordingly, the related net assets were separately presented in current assets and current liabilities as held for sale on the consolidated balance sheets as of December 31, 2022, up until the close of the transaction . The held for sale classification also resulted in ceasing depreciation and amortization on the designated assets. The Share Purchase Agreement between Ingenio, LLC (“Ingenio”) and the Company closed on March 20, 2023. In accordance with the Share Purchase Agreement, the Company sold all of the issued and outstanding shares of Kasamba for $16.9 million which was received in cash upon closing; and $2.6 million deferred payment to be received within a year of the close transaction date, which was included in Prepaid expenses and other current assets on the Company’s condensed consolidated balance sheets as of March 31, 2023. $11.8 million was required to be held in various escrow accounts for up to 15 months, and was included in restricted cash on the Company’s consolidated balance sheets; however, $9.8 million of this escrow amount was released as of December 31, 2023 . In June 2024, restricted cash of $2.0 million was released and is accounted for as Cash and cash equivalents on the condensed consolidated balance sheet as of June 30, 2024. The transaction resulted in a gain of $17.6 million, which was recognized and presented separately as a gain on divestiture on the Company’s consolidated statements of operations during the year ended December 31, 2023. During the six months ended June 30, 2024 , the Company recognize d $1.8 million of post-closing adjustments pertaining to the final agreement amount which is recorded in General and administrative expenses in the condensed consolidated statement of operations.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net loss (in thousands)	$ 41,795	$ (35,631)	$ 10,822	$ (17,420)	$ 6,164	$ (6,598)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Description of Business and B_2

Description of Business and Basis of Presentation (Policies)	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying condensed consolidated financial statements, and the financial data and other information disclosed in the notes to the condensed consolidated financial statements as of June 30, 2024 and for the three and six months ended June 30, 2024 are unaudited. In the opinion of management, the unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for a fair presentation of the Company’s condensed consolidated financial position, results of operations, comprehensive loss, and cash flows for the interim periods presented. The results of operations for any interim period are not necessarily indicative of the results of operations for any other future interim period or for a full fiscal year. The condensed consolidated balance sheet as of December 31, 2023 has been derived from audited consolidated financial statements at that date. Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the year ended December 31, 2023 included in the Company’s Annual Report on Form 10-K filed with the SEC on March 4, 2024 (as amended on April 29, 2024) .
Principles of Consolidation	Principles of Consolidation The unaudited condensed consolidated financial statements reflect the operations of LivePerson and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. These estimates are based on information available as of the date of the condensed consolidated financial statements. On a regular basis, management evaluates these estimates and assumptions. Items subject to such estimates and assumptions include, but are not limited to: • stock-based compensation expense; • allowance for credit losses; • the period of benefit for deferred contract acquisition costs; • valuation of goodwill; • valuation and useful lives of other long-lived assets; • fair value of assets acquired and liabilities assumed in business combinations; • income taxes; • recognition, measurement, and disclosure of contingent liabilities; and • estimated fair values of convertible notes and warrants. As of the date of issuance of the financial statements, the Company is not aware of any material specific events or circumstances that would require it to update its estimates, judgments, or to revise the carrying values of its assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the Company’s condensed consolidated financial statements.
Recently Adopted and Issued Accounting Pronouncements	Recently Adopted Accounting Pronouncements In June 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2022-03, Fair Value Measurement (Topic 820), Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions to clarify that a contractual restriction on the sale of an equity security is not considered part of a unit of account of the equity security, and, therefore, is not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The amendments also require the following disclosures for equity securities subject to the contractual sale restrictions: 1.) The fair value of equity securities subject to the contractual sale restrictions reflected on the balance sheet. 2.) The nature and remaining duration of the restriction(s). 3.) The circumstances that could cause a lapse in the restriction(s). This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within those financial years. The Company adopted this guidance on January 1, 2024, which did not have a material effect on the Company’s condensed consolidated financial statements. Recently Issued Accounting Pronouncements In March 2024, the FASB issued ASU 2024-01, Compensation—Stock Compensation (Topic 718) : Scope Application of Profits Interest and Similar Awards , which provides illustrative guidance to help entities determine whether profits interest and similar awards should be accounted for as share-based payment arrangements within the scope of FASB Accounting Standards Codification (“ASC”) 718, Compensation—Stock Compensation . Specifically, the amendments in ASU 2024-01 add an illustrative example that includes four fact patterns to demonstrate how an entity should apply the scope guidance in paragraph 718-10-15-3 to determine whether a profits interest award should be accounted for in accordance with Topic 718. The guidance in ASU 2024-01 applies to all entities that issue profits interest awards as compensation to employees or non-employees in exchange for goods or services. The amendments in this update are effective for annual periods beginning after December 15, 2024, and interim periods within those annual periods. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. ASU 2024-01 should be applied either retrospectively or prospectively. The Company does not expect this standard to have a material impact on its condensed consolidated financial statements and related disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. The updated standard is effective for annual periods beginning after December 15, 2023. As of June 30, 2024, the Company has one operating and reportable segment and therefore does not expect this standard to have a material impact on its condensed consolidated financial statements and related disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures , which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company does not expect this standard to have a material impact on its condensed consolidated financial statements and related disclosures. In August 2023, the FASB issued ASU 2023-05, Business Combinations—Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement , which addresses the accounting for contributions made to a joint venture, upon formation, in a joint venture’s separate financial statements. The amendments require certain joint ventures to apply a new basis of accounting upon formation by recognizing and initially measuring most of their assets and liabilities at fair value. The objectives of the amendments are to provide decision-useful information to investors and other allocators of capital in a joint venture’s financial statements and also to reduce diversity in practice. ASU 2023-05 is effective for both public and private joint venture entities with a formation date on or after January 1, 2025. Early adoption is permitted. Entities may elect to apply the guidance retrospectively to joint ventures with a formation date prior to

Description of Business and B_3

Description of Business and Basis of Presentation (Tables)	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure	The following table presents the detail of prepaid expenses and other current assets as of the dates presented: June 30, December 31, (In thousands) Prepaid software maintenance $ 8,189 $ 8,592 VAT receivable 4,177 4,399 Prepaid server maintenance 1,606 2,634 Prepaid - other 1,158 2,599 Other assets 3,002 8,757 Total prepaid expenses and other current assets $ 18,132 $ 26,981

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
	Jun. 30, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table presents the Company’s revenues disaggregated by revenue source: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (In thousands) (In thousands) Revenue: Hosted services (1) $ 67,316 $ 81,286 $ 138,811 $ 168,624 Professional services 12,559 16,236 26,213 36,559 Total revenue $ 79,875 $ 97,522 $ 165,024 $ 205,183 (1) On March 20, 2023, the Company completed the sale of Kasamba and therefore ceased recognizing revenue related to Kasamba effective on the transaction close date. Further, this sale eliminated the entire Consumer segment, as a result of which revenue is presented within a single condensed consolidated segment. Hosted services includes $7.2 million of revenue related to Kasamba for the six months ended June 30, 2023.
Schedule of Revenue by Geographic Region	The following table presents the Company’s revenues attributable to operations by region for the periods presented: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (In thousands) (In thousands) Americas (1) $ 56,385 $ 70,907 $ 118,410 $ 143,221 EMEA (2) 14,559 14,933 28,780 31,115 APAC (3) 8,931 11,682 17,834 30,847 Total revenue $ 79,875 $ 97,522 $ 165,024 $ 205,183 —————————————— (1) United States, Canada, Latin America and South America (“Americas”) (2) Europe, the Middle East and Africa (“EMEA”) (3) Asia-Pacific (“APAC”)
Schedule Of Receivables, Contract Acquisition Costs, And Deferred Revenue	The opening and closing balances of the Company’s accounts receivable, unbilled receivables, contract acquisition costs, net, and deferred revenues are as follows: Accounts Receivable Unbilled Receivable Contract Acquisition Costs, Net (Non-current) Deferred Revenue (Current) Deferred Revenue (In thousands) Balance as of December 31, 2022 $ 53,468 $ 33,069 $ 43,804 $ 84,494 $ 174 Increase (decrease), net 6,914 (11,649) (6,450) (2,636) 9 Balance as of December 31, 2023 $ 60,382 $ 21,420 $ 37,354 $ 81,858 $ 183 Decrease, net (18,800) (6,651) (490) (2,502) (106) Balance as of June 30, 2024 $ 41,582 $ 14,769 $ 36,864 $ 79,356 $ 77
Schedule of Allowance for Uncollectible Accounts	The activity in the allowance for credit losses is as follows: June 30, December 31, (In thousands) Balance, beginning of year $ 9,290 9,239 Additions charged to costs and expenses 8,928 3,319 Deductions/write-offs (8,862) (3,268) Balance, end of period $ 9,356 $ 9,290

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	6 Months Ended
	Jun. 30, 2024
Earnings Per Share [Abstract]
Reconciliation of Shares Used in Calculating Basic and Diluted Earnings Per Share	Reconc iliation of shares used in calculating basic and diluted net income (loss) per share for the three and six months ended June 30, 2024 and 2023, is as follows: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (In thousands, except per share amounts) Numerator: Net income (loss) available to stockholders for basic net income per share $ 41,795 $ 10,822 $ 6,164 $ (6,598) Gain on debt extinguishment (73,083) — (73,083) — Interest on assumed conversion of convertible notes, net of tax — 136 — — Net (loss) income available to stockholders for diluted net income per share $ (31,288) $ 10,958 $ (66,919) $ (6,598) Denominator: Weighted-average shares used to compute basic net income (loss) per share 88,708,514 76,902,416 88,396,816 76,341,729 Weighted-average effect of dilutive securities: Stock options and employee stock purchase plan — 98,143 — — Restricted stock units — 166,156 — — Earn-outs — 5,575,251 — — Conversion option of the 2024 Notes — 1,878,810 — — Conversion option of the 2026 Notes 6,269,720 6,879,283 6,576,185 — Weighted-average shares used to compute diluted net (loss) income per share 94,978,234 91,500,059 94,973,001 76,341,729 Net income (loss) per share: Basic $ 0.47 $ 0.14 $ 0.07 $ (0.09) Diluted $ (0.33) $ 0.12 $ (0.70) $ (0.09)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	As of June 30, 2024 2023 Shares subject to outstanding common stock options and employee stock purchase plan 2,880,837 3,541,432 Restricted stock units 8,907,079 3,738,894 Earn-outs — 5,575,251 Conversion option of the 2024 Notes 612,396 1,878,810 Conversion option of the 2026 Notes — 6,879,283 Warrants 9,746,723 — Total 22,147,035 21,613,670

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Jun. 30, 2024
Segment Reporting [Abstract]
Schedule of Long-Lived Assets by Geographic Region	The Company is domiciled in the United States and has international operations around the globe. The following table presents the Company’s long-lived assets by geographic region as of June 30, 2024 and December 31, 2023: June 30, December 31, 2024 2023 (In thousands) United States $ 412,660 $ 438,420 Germany 41,497 45,424 Australia 11,655 11,660 Netherlands 5,760 5,863 Other (1) 11,756 12,438 Total long-lived assets $ 483,328 $ 513,805 —————————————— (1) United Kingdom, Japan, France, Italy, Spain, Canada, and Singapore

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The changes in the carrying amount of goodwill as of June 30, 2024 and December 31, 2023 are as follows: Consolidated (In thousands) Balance as of December 31, 2022 $ 296,214 Adjustments to goodwill: Goodwill impairment (1) (11,895) Foreign exchange adjustment 1,312 Balance as of December 31, 2023 $ 285,631 Adjustments to goodwill: Goodwill impairment (1) (3,627) Foreign exchange adjustment (1,278) Balance as of June 30, 2024 $ 280,726 —————————————— (1) The sum of these amounts represents the accumulated goodwill impairment balance in our operating segment as of June 30, 2024.
Summary of Intangible Assets	Intangible assets are summarized as follows: June 30, 2024 Gross Accumulated Net Carrying Amount Weighted (In thousands) (In years) Amortizing intangible assets: Technology $ 94,559 $ (67,998) $ 26,561 5.0 Customer relationships 32,060 (20,593) 11,467 10.0 Patents 16,497 (2,226) 14,271 13.6 Trademarks 1,404 (826) 578 5.0 Trade names 1,044 (1,044) — 2.8 Other 914 (835) 79 4.1 Total $ 146,478 $ (93,522) $ 52,956 December 31, 2023 Gross Accumulated Net Carrying Amount Weighted (In thousands) (In years) Amortizing intangible assets: Technology $ 94,549 $ (60,465) $ 34,084 5.0 Customer relationships 32,025 (19,542) 12,483 10.0 Patents 15,350 (1,916) 13,434 12.9 Trademarks 1,400 (707) 693 5.0 Trade names 1,044 (672) 372 2.8 Other 914 (355) 559 4.1 Total $ 145,282 $ (83,657) $ 61,625
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	As of June 30, 2024, estimated annual amortization expense for the next five years and thereafter is as follows: Estimated Amortization Expense (In thousands) Remainder of 2024 $ 7,307 2025 14,205 2026 11,519 2027 1,411 2028 1,343 Thereafter 17,171 Total $ 52,956

Property and Equipment (Tables)

Property and Equipment (Tables)	6 Months Ended
	Jun. 30, 2024
Property, Plant and Equipment [Abstract]
Summary of Property and Equipment	The following table presents the detail of property and equipment, net for the periods presented: June 30, December 31, Useful life (In thousands) (In years) Internal-use software development costs $ 183,169 $ 181,079 5 Computer equipment and software 126,181 123,580 3 to 5 Furniture, equipment and building improvements 328 327 The lesser of 5 or estimated useful life Finance lease right-of-use assets 238 3,060 2 Property and equipment, at cost 309,916 308,046 Less: accumulated depreciation (202,968) (188,721) Property and equipment, net $ 106,948 $ 119,325 Total depreciation included in our condensed consolidated statements of operations for the three and six months ended June 30, 2024 and 2023 is as follows: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (In thousands) (In thousands) Cost of revenue $ 1,771 $ 2,186 $ 3,453 $ 4,433 Sales and marketing 740 741 1,640 1,467 General and administrative 33 139 191 300 Product development 5,170 6,660 10,655 10,888 Total $ 7,714 $ 9,726 $ 15,939 $ 17,088

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	6 Months Ended
	Jun. 30, 2024
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	The following table presents the detail of accrued expenses and other current liabilities for the periods presented: June 30, December 31, (In thousands) Professional services and consulting and other vendor fees $ 48,150 $ 67,585 Payroll and other employee-related costs 10,521 20,767 Warrants liability 5,266 — Finance lease liability 108 3,037 Restructuring 1,344 2,076 Sales commissions 475 734 Non-income tax 556 556 Other 1,817 2,269 Total $ 68,237 $ 97,024

Convertible Senior Notes, Net_2

Convertible Senior Notes, Net of Current Portion, Capped Call Transactions, and Warrants (Tables)	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
Schedule of Carrying Amount of Liability Component of Convertible Debt	The net carrying amount of the Notes as of June 30, 2024 and December 31, 2023 is as follows: June 30, 2024 December 31, 2023 2026 Notes 2029 Notes Total 2024 Notes 2026 Notes Total (In thousands) (In thousands) Principal $ 361,204 $ 150,000 $ 511,204 $ 72,492 $ 517,500 $ 589,992 Unamortized debt discount — (31,578) (31,578) — — — Unamortized issuance costs (3,472) (7,488) (10,960) (99) (5,935) (6,034) Total net carrying value $ 357,732 $ 110,934 $ 468,666 $ 72,393 $ 511,565 $ 583,958 Less: short-term debt, net — — — 72,393 — 72,393 Long-term debt, net $ 357,732 $ 110,934 $ 468,666 $ — $ 511,565 $ 511,565
Schedule of Interest Expense Incurred	The following table sets forth the interest expense recognized related to the Notes: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (In thousands) (In thousands) Contractual interest expense $ 1,591 $ 128 $ 1,681 $ 569 Amortization of debt discount 301 — 301 — Amortization of debt issuance costs 531 1,807 1,042 2,727 Total interest expense $ 2,423 $ 1,935 $ 3,024 $ 3,296

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2024
Leases [Abstract]
Supplemental cash flow information related to leases	Supplemental cash flow information related to leases for the three and six months ended June 30, 2024 and 2023 is as follows: Three Months Ended Six Months Ended June 30, June 30, 2024 2023 2024 2023 (In thousands) (In thousands) Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 579 $ 863 $ 1,421 $ 1,837 Operating cash flows for finance leases 3 13 21 37 Financing cash flows for finance leases 26 968 353 1,926
Schedule of components of lease costs	The components of lease costs for the three and six months ended June 30, 2024 and 2023 are as follows: Three Months Ended Six Months Ended June 30, June 30, 2024 2023 2024 2023 (In thousands) (In thousands) Finance lease cost Amortization of right-of-use assets $ 21 $ 919 $ 355 $ 1,830 Interest 3 13 21 37 Operating lease cost 2,565 2,887 5,467 5,627 Total lease cost $ 2,589 $ 3,819 $ 5,843 $ 7,494 June 30, June 30, Weighted Average Remaining Lease Term: Operating leases 0.6 years 2.1 years Finance leases 1.3 years 1.1 years Weighted Average Discount Rate: Operating leases 7 % 7 % Finance leases 7 % 4 %
Supplemental balance sheet information related to leases	Supplemental balance sheet information related to leases is as follows: Financial Statement Classification June 30, December 31, (In thousands) Assets Operating right-of-use assets Operating lease right-of-use assets $ 260 $ 4,135 Finance right-of-use assets Property and equipment, net 128 3,060 Liabilities Current liabilities: Operating lease liabilities Operating lease liabilities $ 268 $ 2,719 Finance lease liabilities Accrued expenses and other current liabilities 108 3,037 Non-current liabilities: Operating lease liabilities Operating lease liabilities, net of current portion — 2,173 Finance lease liabilities Other liabilities 28 85
Schedule of Future Minimum Lease Payments	Future minimum lease payments under non-cancellable operating and finance leases are immaterial.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Schedule of Financial Assets and Liabilities Measured at Fair Value	The Company’s assets and liabilities that are measured at fair value on a recurring basis, by level, within the fair value hierarchy as of June 30, 2024 and December 31, 2023, are summarized as follows: June 30, 2024 Level 1 Level 2 Level 3 Total (In thousands) Assets Cash equivalents: Money market funds $ 122,884 $ — $ — $ 122,884 Total assets $ 122,884 $ — $ — $ 122,884 Liabilities Warrants liability $ — $ — $ 5,266 $ 5,266 Total liabilities $ — $ — $ 5,266 $ 5,266 December 31, 2023 Level 1 Level 2 Level 3 Total (In thousands) Assets Cash equivalents: Money market funds $ 174,701 $ — $ — $ 174,701 Total assets $ 174,701 $ — $ — $ 174,701
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments	The estimated fair value of outstanding balances of our Notes as of June 30, 2024 and December 31, 2023 are as follows: Level of Hierarchy Fair Value Principal Balance Unamortized Debt Discount Unamortized Debt Issuance Costs Net Carrying Value (In thousands) June 30, 2024 2026 Notes 2 $ 170,516 $ 361,204 $ — $ (3,472) $ 357,732 2029 Notes 2 118,122 150,000 (31,578) (7,488) 110,934 December 31, 2023 2024 Notes 2 $ 71,396 $ 72,492 $ — $ (99) $ 72,393 2026 Notes 2 364,487 517,500 — (5,935) 511,565
Schedule of Changes in Fair Value of Level 3 Liabilities	The changes in fair value of the Level 3 warrants and earn-out liabilities during the six months ended June 30, 2024 and the year ended December 31, 2023 are as follows: June 30, December 31, Balance, beginning of year $ — $ 72,221 Change in fair value of contingent consideration — 4,629 Change in fair value of liability awards — (27,857) Payments — (48,993) Issuance of warrants 5,266 — Balance, end of period $ 5,266 $ —
Fair Value Measurement Inputs and Valuation Techniques	A summary of the Black-Scholes pricing model assumptions used to record the fair value of the Warrants as of June 30, 2024 is as follows: Stock price $ 0.62 Risk free rate 4.41 % Expected life (in years) 10 years Expected volatility 60 %

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]
Summary of Stock Option Activity and Weighted Average Exercise Prices	The following table is a summary of the Company’s stock option activity for the six months ended June 30, 2024: Stock Option Activity Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Options Weighted (In thousands) (Per option) (In years) (In thousands) Balance outstanding as of December 31, 2023 3,137 $ 22.68 4.84 $ 40 Granted 1,000 (1) 1.02 Cancelled or expired (1,256) 22.22 Balance outstanding as of June 30, 2024 2,881 15.38 6.3 1 Options vested and expected to vest 624 6.89 9.29 — Options exercisable as of June 30, 2024 1,692 $ 22.51 4.12 $ 1 —————————————— (1) Represents the CEO Inducement Award, which does not count against the number of shares reserved for issuance under the Company’s 2019 Stock Incentive Plan or the Company’s 2018 Inducement Plan.
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity	The following table is a summary of the Company’s RSU and PRSU activity for the six months ended June 30, 2024: Number of Shares Weighted Average Grant Date Fair Value Aggregate Fair Value (In thousands) (Per share) (In thousands) Balance outstanding as of December 31, 2023 5,064 $ 12.53 $ 19,193 Awarded 5,699 0.99 Vested (969) 16.66 Forfeited (887) 15.82 Non-vested and outstanding as of June 30, 2024 8,907 4.37 5,171 Expected to vest 6,215 $ 4.66 $ 3,608
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award	Total stock-based compensation costs included in our condensed consolidated statements of operations for the three and six months ended June 30, 2024 and 2023 are as follows: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (In thousands) (In thousands) Cost of revenue $ 288 $ (1,232) $ 631 $ 803 Sales and marketing 1,854 2,299 4,309 4,703 General and administrative 2,318 (13,882) 4,116 (11,250) Product development 1,440 (5,333) 4,402 (1,072) Total $ 5,900 $ (18,148) $ 13,458 $ (6,816)

Restructuring (Tables)

Restructuring (Tables)	6 Months Ended
	Jun. 30, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Related Costs	The following table presents the detail of the liability for the Company’s restructuring charges, which is included within Accrued expenses and other current liabilities within the accompanying condensed consolidated balance sheets as of June 30, 2024 and December 31, 2023: June 30, December 31, (In thousands) Balance, beginning of the year $ 2,076 $ 803 IT contract termination (reversals) costs (568) 5,744 Severance and other compensation associated costs 6,996 16,920 Cash payments (7,160) (21,391) Balance, end of period $ 1,344 $ 2,076 The Company anticipates that payments associated with the employee severance and other compensation associated costs reflected in the table above will be substantially completed by December 31, 2024.
Schedule of Restructuring Liability by Cost Type	The following table presents the detail of expenses for the Company’s restructuring charges for the three months and six months ended June 30, 2024 and 2023: Three Months Ended Six Months Ended June 30, June 30, 2024 2023 2024 2023 (In thousands) (In thousands) IT contract termination reversals $ (1,284) $ — $ (568) $ — Severance and other associated costs 4,403 2,387 6,996 13,902 Total restructuring costs $ 3,119 $ 2,387 $ 6,428 $ 13,902

Description of Business and B_4

Description of Business and Basis of Presentation (Details)	3 Months Ended	6 Months Ended
	Jun. 30, 2023 segment	Jun. 30, 2024 segment connection
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of connections and conversations powered each month | connection		1,000,000,000
Number of operating segments	2	1
Number of reportable segments		1

Description of Business and B_5

Description of Business and Basis of Presentation - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Accounting Policies [Abstract]
Prepaid software maintenance	$ 8,189	$ 8,592
VAT receivable	4,177	4,399
Prepaid server maintenance	1,606	2,634
Prepaid - other	1,158	2,599
Other assets	3,002	8,757
Prepaid expenses and other current assets (Note 1)	$ 18,132	$ 26,981

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disaggregation of Revenue [Line Items]
Revenue from related parties	$ 79,875	$ 97,522	$ 165,024	$ 205,183
Hosted Services - Business
Disaggregation of Revenue [Line Items]
Revenue from related parties	67,316	81,286	138,811	168,624
Professional Services
Disaggregation of Revenue [Line Items]
Revenue from related parties	$ 12,559	16,236	$ 26,213	$ 36,559
Hosted Services - Consumer | Kasamba, Inc.
Disaggregation of Revenue [Line Items]
Revenue from related parties		$ 7,200

Revenue Recognition - Narrative

Revenue Recognition - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	$ 283,000		$ 283,000
Recognition of deferred revenue	22,200	$ 28,900	64,700	$ 73,000
Amortization of acquisition costs	$ 4,800	$ 5,100	$ 9,700	$ 13,400
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	94%		94%
Revenue, remaining performance obligation, expected timing of satisfaction, period	24 months		24 months

Revenue Recognition - Revenue b

Revenue Recognition - Revenue by Geographic Location (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disaggregation of Revenue [Line Items]
Revenue from related parties	$ 79,875	$ 97,522	$ 165,024	$ 205,183
Total Americas
Disaggregation of Revenue [Line Items]
Revenue from related parties	56,385	70,907	118,410	143,221
EMEA
Disaggregation of Revenue [Line Items]
Revenue from related parties	14,559	14,933	28,780	31,115
APAC
Disaggregation of Revenue [Line Items]
Revenue from related parties	$ 8,931	$ 11,682	$ 17,834	$ 30,847

Revenue Recognition - Receivabl

Revenue Recognition - Receivables and Deferred Revenue (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Contract Balances [Roll Forward]
Accounts receivable, opening balance	$ 81,802
Accounts receivable, ending balance	56,351	$ 81,802
Contract acquisition costs noncurrent, opening balance	37,354	43,804
Contract acquisition costs noncurrent, increase (decrease), net	(490)	(6,450)
Contract acquisition costs noncurrent, ending balance	36,864	37,354
Deferred revenue (current), opening balance	81,858	84,494
Deferred revenue (current), increase (decrease), net	(2,502)	(2,636)
Deferred revenue (current), ending balance	79,356	81,858
Deferred revenue (long-term), opening balance	183	174
Deferred revenue (long-term), increase (decrease), net	(106)	9
Deferred revenue (long-term), ending balance	77	183
Billed receivable
Contract Balances [Roll Forward]
Accounts receivable, opening balance	60,382	53,468
Accounts receivable, increase (decrease), net	(18,800)	6,914
Accounts receivable, ending balance	41,582	60,382
Unbilled receivable
Contract Balances [Roll Forward]
Accounts receivable, opening balance	21,420	33,069
Accounts receivable, increase (decrease), net	(6,651)	(11,649)
Accounts receivable, ending balance	$ 14,769	$ 21,420

Revenue Recognition - Accounts

Revenue Recognition - Accounts Receivable (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Mar. 31, 2024	Jun. 30, 2024	Jun. 30, 2023
Allowance for Doubtful Accounts
Beginning balance	$ 9,290	$ 9,290	$ 9,239
Additions charged to costs and expenses	3,319	8,928	$ 1,809
Deductions/write-offs	$ (3,268)	(8,862)
Ending balance		$ 9,356

Net Income (Loss) Per Share - N

Net Income (Loss) Per Share - Narrative (Details) - shares	3 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2019
Debt Instrument [Line Items]
Anti-dilutive common stock awards not included in earnings per share calculation (in shares)		22,147,035	21,613,670
Shares subject to outstanding common stock options and employee stock purchase plan
Debt Instrument [Line Items]
Anti-dilutive common stock awards not included in earnings per share calculation (in shares)	3,800,000	2,880,837	3,541,432
Restricted stock units
Debt Instrument [Line Items]
Anti-dilutive common stock awards not included in earnings per share calculation (in shares)	3,200,000	8,907,079	3,738,894
2024 Notes | Convertible Debt
Debt Instrument [Line Items]
Debt instrument stated rate (percent)		0.75%		0.75%

Net Income (Loss) Per Share - R

Net Income (Loss) Per Share - Reconciliation of Shares Used in Calculating Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net income (loss) available to common stockholders, basic	$ 41,795	$ 10,822	$ 6,164	$ (6,598)
Gain on debt extinguishment	(73,083)	0	(73,083)	0
Interest on assumed conversion of convertible notes, net of tax	0	136	0	0
Net (loss) income available to stockholders for diluted net income per share	$ (31,288)	$ 10,958	$ (66,919)	$ (6,598)
Weighted-average shares used to compute basic net income per share (in shares)	88,708,514	76,902,416	88,396,816	76,341,729
Earn-outs (in shares)	0	5,575,251	0	0
Weighted-average shares used to compute diluted net income per share (in shares)	94,978,234	91,500,059	94,973,001	76,341,729
Basic (in dollars per share)	$ 0.47	$ 0.14	$ 0.07	$ (0.09)
Diluted (in dollars per share)	$ (0.33)	$ 0.12	$ (0.70)	$ (0.09)
2024 Notes
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Dilutive effect of assumed conversion of debt (in shares)	0	1,878,810	0	0
2026 Notes
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Dilutive effect of assumed conversion of debt (in shares)	6,269,720	6,879,283	6,576,185	0
Restricted stock units
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Dilutive effect of outstanding common stock options and employee stock purchase plan and restricted stock units (in shares)	0	166,156	0	0
Stock Option
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Dilutive effect of outstanding common stock options and employee stock purchase plan and restricted stock units (in shares)	0	98,143	0	0

Net Income (Loss) Per Share - S

Net Income (Loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of EPS (Details) - shares	3 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock awards not included in earnings per share calculation (in shares)		22,147,035	21,613,670
Shares subject to outstanding common stock options and employee stock purchase plan
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock awards not included in earnings per share calculation (in shares)	3,800,000	2,880,837	3,541,432
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock awards not included in earnings per share calculation (in shares)	3,200,000	8,907,079	3,738,894
Fair Value Earnout
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock awards not included in earnings per share calculation (in shares)		0	5,575,251
Conversion option of the Notes | 2024 Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock awards not included in earnings per share calculation (in shares)		612,396	1,878,810
Conversion option of the Notes | 2026 Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock awards not included in earnings per share calculation (in shares)		0	6,879,283
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock awards not included in earnings per share calculation (in shares)		9,746,723	0

Segment Information - Narrative

Segment Information - Narrative (Details) - segment	3 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2024
Segment Reporting [Abstract]
Number of operating segments	2	1
Number of reportable segments		1

Segment Information - Long-Live

Segment Information - Long-Lived Assets by Geographic Region (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Segment Reporting Information [Line Items]
Total long-lived assets	$ 483,328	$ 513,805
United States
Segment Reporting Information [Line Items]
Total long-lived assets	412,660	438,420
Germany
Segment Reporting Information [Line Items]
Total long-lived assets	41,497	45,424
Australia
Segment Reporting Information [Line Items]
Total long-lived assets	11,655	11,660
Netherlands
Segment Reporting Information [Line Items]
Total long-lived assets	5,760	5,863
Other
Segment Reporting Information [Line Items]
Total long-lived assets	$ 11,756	$ 12,438

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Changes in Carrying Amount of Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Goodwill [Roll Forward]
Goodwill, beginning balance			$ 285,631
Impairment of goodwill	$ 0	$ 0	(3,627)	$ 0	$ (11,895)
Goodwill, ending balance	280,726		280,726		285,631
Business
Goodwill [Roll Forward]
Goodwill, beginning balance			285,631	296,214	296,214
Impairment of goodwill	0	$ 0	0	$ 0
Foreign exchange adjustment			(1,278)		1,312
Goodwill, ending balance	$ 280,726		$ 280,726		$ 285,631

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Narrative (Details) - USD ($)	3 Months Ended			6 Months Ended		12 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Goodwill [Line Items]
Impairment of goodwill	$ 0		$ 0	$ 3,627,000	$ 0	$ 11,895,000
Amortization of purchased intangible assets	674,000		876,000	1,565,000	1,750,000
Impairment of intangibles and other assets	8,347,000		0	10,568,000	0
Business
Goodwill [Line Items]
Impairment of goodwill	0		0	0	0
WildHealth
Goodwill [Line Items]
Asset impairment charges		$ 3,600,000
WildHealth
Goodwill [Line Items]
Other asset impairment charges		$ 2,200,000
Cost of revenue
Goodwill [Line Items]
Amortization of purchased intangible assets	3,700,000		5,500,000	7,900,000	10,900,000
Amortization of purchased intangibles	$ 3,000,000		$ 4,600,000	$ 6,300,000	$ 9,100,000

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Mar. 31, 2024	Jun. 30, 2024	Dec. 31, 2023
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		$ 146,478	$ 145,282
Accumulated Amortization		(93,522)	(83,657)
Net Carrying Amount		52,956	61,625
Technology
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		94,559	94,549
Accumulated Amortization		(67,998)	(60,465)
Net Carrying Amount		$ 26,561	34,084
Weighted Average Useful Life	5 years	5 years
Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		$ 32,060	32,025
Accumulated Amortization		(20,593)	(19,542)
Net Carrying Amount		$ 11,467	12,483
Weighted Average Useful Life	10 years	10 years
Patents
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		$ 16,497	1,400
Accumulated Amortization		(2,226)	(707)
Net Carrying Amount		$ 14,271	693
Weighted Average Useful Life	2 years 9 months 18 days	13 years 7 months 6 days
Trademarks
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		$ 1,404	1,044
Accumulated Amortization		(826)	(672)
Net Carrying Amount		$ 578	372
Weighted Average Useful Life	5 years	5 years
Trade names
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		$ 1,044	15,350
Accumulated Amortization		(1,044)	(1,916)
Net Carrying Amount		$ 0	13,434
Weighted Average Useful Life	12 years 10 months 24 days	2 years 9 months 18 days
Other
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		$ 914	914
Accumulated Amortization		(835)	(355)
Net Carrying Amount		$ 79	$ 559
Weighted Average Useful Life	4 years 1 month 6 days	4 years 1 month 6 days

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Future Amortization Expense (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Estimated Amortization Expense
Remainder of 2024	$ 7,307
2025	14,205
2026	11,519
2027	1,411
2028	1,343
Thereafter	17,171
Total	$ 52,956	$ 61,625

Property and Equipment (Details

Property and Equipment (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Finance lease right-of-use assets	$ 238	$ 3,060
Property and equipment and finance lease, gross	309,916	308,046
Less: accumulated depreciation	(202,968)	(188,721)
Property and equipment, net	$ 106,948	119,325
Finance lease, term of contract	2 years
Internal-use software development costs
Property, Plant and Equipment [Line Items]
Property and equipment gross	$ 183,169	181,079
Useful life	5 years
Computer equipment and software
Property, Plant and Equipment [Line Items]
Property and equipment gross	$ 126,181	123,580
Computer equipment and software | Minimum
Property, Plant and Equipment [Line Items]
Useful life	3 years
Computer equipment and software | Maximum
Property, Plant and Equipment [Line Items]
Useful life	5 years
Finance lease right-of-use assets
Property, Plant and Equipment [Line Items]
Property and equipment gross	$ 328	$ 327
Useful life	5 years

Property and Equipment - Narrat

Property and Equipment - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Property, Plant and Equipment [Abstract]
Depreciation	$ 7,700,000	$ 9,700,000	$ 15,900,000	$ 17,100,000
Impairment, Long-Lived Asset, Held-for-Use	$ 8,300,000	$ 0	$ 8,300,000	$ 0

Property and Equipment - Schedu

Property and Equipment - Schedule of Depreciation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 7,714	$ 9,726	$ 15,939	$ 17,088
Cost of revenue
Property, Plant and Equipment [Line Items]
Depreciation expense	1,771	2,186	3,453	4,433
Sales and marketing
Property, Plant and Equipment [Line Items]
Depreciation expense	740	741	1,640	1,467
General and administrative
Property, Plant and Equipment [Line Items]
Depreciation expense	33	139	191	300
Product development
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 5,170	$ 6,660	$ 10,655	$ 10,888

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Professional services and consulting and other vendor fees	$ 48,150	$ 67,585
Payroll and other employee-related costs	10,521	20,767
Warrants liability	5,266	0
Finance lease liability	108	3,037
Restructuring	1,344	2,076	$ 803
Sales commissions	475	734
Non-income tax	556	556
Other	1,817	2,269
Total	$ 68,237	$ 97,024

Convertible Senior Notes, Net_3

Convertible Senior Notes, Net of Current Portion, Capped Call Transactions, and Warrants - Narrative (Details) $ / shares in Units, $ in Thousands					1 Months Ended		3 Months Ended			6 Months Ended		12 Months Ended
	Jun. 13, 2024 USD ($)	Jun. 03, 2024 USD ($) $ / shares shares	Mar. 21, 2023 USD ($)	Dec. 31, 2020 USD ($) day	Jun. 30, 2024 USD ($) day segment d	Dec. 31, 2020 USD ($) day shares	Jun. 30, 2024 USD ($)	Mar. 31, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Dec. 31, 2020 USD ($)	Jun. 30, 2024 $ / shares	Dec. 31, 2023 USD ($)	Dec. 31, 2023 $ / shares	Dec. 31, 2022 $ / shares	Mar. 31, 2019 USD ($)
Debt Instrument [Line Items]
Debt instrument, repurchase amount			$ 149,700
Debt instrument, increase (decrease), net			157,500
Gain on debt extinguishment							$ 73,083		$ 1,151	$ 73,083	$ 7,200
Convertible senior notes, net of current portion (Note 8)					$ 468,666		468,666			468,666				$ 511,565
Number of shares of common stock covered by called caps (shares) | shares						6,880,000
Reduction to additional paid-in-capital related to called caps						$ 46,100
Interest expense							2,400		1,900		3,300
Common stock, par value (in dollars per share) | (per share)													$ 1		$ 1	$ 0.001
Amortization of debt issuance costs and debt discount										1,343	$ 2,727
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 0.75
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares		9,746,723
Class of Warrant or Right, Post-Exercise Basis, Percentage					4.99%
Class of Warrant or Right, Post-Exercise Basis, Term of Investor Notice					61 days
Class of Warrant or Right, Post-Exercise Basis, Maximum Percentage					9.99%
Warrants liability					$ 5,266		$ 5,266			$ 5,266
Share-Settled Warrants
Debt Instrument [Line Items]
Warrants and Rights Outstanding, Term		10 years
Cash-Settled Warrants
Debt Instrument [Line Items]
Warrants and Rights Outstanding, Term		10 years			10 years		10 years			10 years
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 0.75
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares		2,344,775
Class of Warrant or Right, Available Cash					$ 100,000		$ 100,000			$ 100,000
Class of Warrant or Right, Settlement Amount, Annualized Interest Rate					6%
Convertible Debt
Debt Instrument [Line Items]
Principal Balance					$ 511,204		511,204			511,204				589,992
Unamortized issuance costs					10,960		10,960			10,960				6,034
Unamortized debt discount					31,578		31,578			31,578				0
Total net carrying value					468,666		468,666			468,666				583,958
2024 Notes
Debt Instrument [Line Items]
Principal Balance					72,000		72,000			72,000
Debt instrument, increase (decrease), net			$ 228,300
Gain on debt extinguishment								$ 7,200
Unamortized debt discount														0
2024 Notes | Previously Reported
Debt Instrument [Line Items]
Gain on debt extinguishment									6,100
Payment for debt extinguishment or debt prepayment cost									$ 500
2024 Notes | Revision of Prior Period, Adjustment
Debt Instrument [Line Items]
Gain on debt extinguishment								$ 1,100
2024 Notes | Convertible Debt
Debt Instrument [Line Items]
Principal Balance					$ 72,500		$ 72,500			$ 72,500				72,492			$ 230,000
Debt instrument stated rate (percent)					0.75%		0.75%			0.75%							0.75%
Unamortized issuance costs														99
Unamortized debt discount														0
Total net carrying value														72,393
2026 Notes
Debt Instrument [Line Items]
Debt instrument, repurchase amount	$ 10,300
Debt instrument, increase (decrease), net										$ 154,700
Gain on debt extinguishment							$ 5,000
Convertible senior notes, net of current portion (Note 8)					$ 357,800		357,800			357,800
Unamortized debt discount					0		0			0				0
Repayments of Convertible Debt	$ 4,900
2026 Notes | Investor
Debt Instrument [Line Items]
Principal Balance		$ 146,000			146,000		146,000			146,000
2026 Notes | Debt Instrument, Redemption, First Lien Convertible Notes
Debt Instrument [Line Items]
Principal Balance					$ 60,000		60,000			60,000
Debt Instrument, Threshold Before Maturity					91 days
2026 Notes | Convertible Debt
Debt Instrument [Line Items]
Principal Balance				$ 517,500	$ 361,204	$ 517,500	361,204			361,204		$ 517,500		517,500
Debt instrument, increase (decrease), net										156,300
Proceeds from debt offering, net of debt issuance costs												$ 505,300
Debt Instrument, Convertible, Conversion Ratio				0.0132933
Percentage of principal amount paid if repurchase due to fundamental change (percent)						100%
Unamortized issuance costs					$ 3,472		$ 3,472			$ 3,472				5,935
Remaining amortization period for debt discount and debt issuance costs					2 years 4 months 24 days		2 years 4 months 24 days			2 years 4 months 24 days
Effective interest rate (percent)							0.40%			0.40%
Convertible debt conversion price (in dollars per share) | $ / shares																75.23
Unamortized debt discount					$ 0		$ 0			$ 0				0
Total net carrying value					357,732		357,732			357,732				$ 511,565
Debt Instrument, Convertible, Threshold Principal Amount					60,000
2026 Notes | Convertible Debt | Debt Conversion Terms One
Debt Instrument [Line Items]
Threshold trading days in consideration of note conversion | day						20
Threshold consecutive trading days in analysis of conversion price | day						30
Threshold percentage of stock price if converted						130%
2026 Notes | Convertible Debt | Debt Conversion Terms Two
Debt Instrument [Line Items]
Threshold trading days in consideration of note conversion | day				5
Threshold consecutive trading days in analysis of conversion price | day				5
Threshold for five day period, product of sale price of common stock and conversion rate of notes						98%
Capped calls
Debt Instrument [Line Items]
Capped caps initial strike price (in dollars per share) | $ / shares																75.23
Capped caps initial cap price (in dollars per share) | $ / shares																$ 105.58
2029 Notes
Debt Instrument [Line Items]
Unamortized debt discount					31,578		31,578			31,578
2029 Notes | Investor
Debt Instrument [Line Items]
Principal Balance					100,000		100,000			100,000
Debt instrument, repurchase amount					$ 50,000		50,000			50,000
Class of Warrant Or Right, Additional Amount Authorized For Purchase		$ 50,000
2029 Notes | Debt Instrument, Redemption, First Lien Convertible Notes
Debt Instrument [Line Items]
Percentage of principal amount paid if repurchase due to fundamental change (percent)					100%
Debt Instrument, Redemption Price, Discount Percentage, Basis Points					50
2029 Notes | Convertible Debt
Debt Instrument [Line Items]
Principal Balance					$ 150,000		150,000			150,000
Debt Instrument, Convertible, Conversion Ratio					0.0132933
Unamortized issuance costs					$ 7,488		$ 7,488			$ 7,488
Remaining amortization period for debt discount and debt issuance costs					5 years		5 years			5 years
Unamortized debt discount					$ 31,578		$ 31,578			$ 31,578
Total net carrying value					110,934		110,934			110,934
Amortization of debt issuance costs and debt discount					7,500
Debt Instrument, Covenant, Maximum Debt Junior In Lien Property					150,000
Debt Instrument, Covenant, Minimum Required Cash Balance					$ 60,000
Debt Instrument, Convertible, Trading Day Observation Period | d					50
Long-Term Debt, Fair Value					$ 118,100		$ 118,100			$ 118,100
Debt Instrument, Interest Rate, Effective Percentage					19.18%		19.18%			19.18%
Debt issuance costs attributable to liability					$ 7,600		$ 7,600			$ 7,600
Debt Instrument, Discount, Gross					$ 31,900		$ 31,900			$ 31,900
2029 Notes | Convertible Debt | Debt Conversion Terms One
Debt Instrument [Line Items]
Threshold trading days in consideration of note conversion | day					20
Threshold consecutive trading days in analysis of conversion price | day					30
Threshold percentage of stock price if converted					130%
2029 Notes | Convertible Debt | Debt Conversion Terms Two
Debt Instrument [Line Items]
Threshold trading days in consideration of note conversion | segment					5
Threshold consecutive trading days in analysis of conversion price | segment					5
Threshold for five day period, product of sale price of common stock and conversion rate of notes					98%
2029 Notes | Convertible Debt | Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed					106.50%
Debt Instrument, Redemption Price, Accrued And Unpaid Interest, Percentage					106.50%
2029 Notes | Convertible Debt | Debt Instrument, Redemption, Period Two
Debt Instrument [Line Items]
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed					103.25%
Debt Instrument, Redemption Price, Accrued And Unpaid Interest, Percentage					103.25%
2029 Notes | Convertible Debt | Debt Instrument, Redemption, Period Three
Debt Instrument [Line Items]
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed					113%
Debt Instrument, Redemption Price, Accrued And Unpaid Interest, Percentage					113%
2029 Notes | Convertible Debt | Debt Instrument, Redemption, Fundamental Change
Debt Instrument [Line Items]
Percentage of principal amount paid if repurchase due to fundamental change (percent)					100%
Debt Instrument, Redemption Price, Remaining Future Interest Payments, Percentage					66%
Debt Instrument, Redemption Price, Discount Percentage, Basis Points					50
2029 Notes | Convertible Debt | Earlier Of The Date of Issuance of Delayed Draw Notes And December 15. 2026
Debt Instrument [Line Items]
Debt instrument stated rate (percent)					10.83%		10.83%			10.83%
Debt Instrument, Interest Rate, Stated Percentage, Cash					4.17%		4.17%			4.17%
Debt Instrument, Interest Rate, Stated Percentage, Paid In Kind					6.66%		6.66%			6.66%
2029 Notes | Convertible Debt | Date of Issuance of Delayed Draw Notes And Prior to December 15, 2026
Debt Instrument [Line Items]
Debt instrument stated rate (percent)					11.375%		11.375%			11.375%
Debt Instrument, Interest Rate, Stated Percentage, Cash					4.375%		4.375%			4.375%
Debt Instrument, Interest Rate, Stated Percentage, Paid In Kind					7%		7%			7%
2029 Notes | Convertible Debt | On Or After December 15, 2026
Debt Instrument [Line Items]
Debt instrument stated rate (percent)					13%		13%			13%
Debt Instrument, Interest Rate, Stated Percentage, Cash					5%		5%			5%
Debt Instrument, Interest Rate, Stated Percentage, Paid In Kind					8%		8%			8%
Exchange and Purchase Agreement
Debt Instrument [Line Items]
Gain on debt extinguishment							$ 68,100

Convertible Senior Notes, Net_4

Convertible Senior Notes, Net of Current Portion, Capped Call Transactions, and Warrants - Schedule of Carrying Amount of Liability Component of Convertible Debt (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2020	Mar. 31, 2019
2026 Notes
Debt Instrument [Line Items]
Unamortized debt discount	$ 0	$ 0
2029 Notes
Debt Instrument [Line Items]
Unamortized debt discount	(31,578)
2024 Notes
Debt Instrument [Line Items]
Principal Balance	72,000
Unamortized debt discount		0
Convertible Debt
Debt Instrument [Line Items]
Principal Balance	511,204	589,992
Unamortized debt discount	(31,578)	0
Unamortized issuance costs	(10,960)	(6,034)
Total net carrying value	468,666	583,958
Less: short-term debt, net	0	72,393
Long-term debt, net	468,666	511,565
Convertible Debt | 2026 Notes
Debt Instrument [Line Items]
Principal Balance	361,204	517,500	$ 517,500
Unamortized debt discount	0	0
Unamortized issuance costs	(3,472)	(5,935)
Total net carrying value	357,732	511,565
Less: short-term debt, net	0	0
Long-term debt, net	357,732	511,565
Convertible Debt | 2029 Notes
Debt Instrument [Line Items]
Principal Balance	150,000
Unamortized debt discount	(31,578)
Unamortized issuance costs	(7,488)
Total net carrying value	110,934
Less: short-term debt, net	0
Long-term debt, net	110,934
Convertible Debt | 2024 Notes
Debt Instrument [Line Items]
Principal Balance	$ 72,500	72,492		$ 230,000
Unamortized debt discount		0
Unamortized issuance costs		(99)
Total net carrying value		72,393
Less: short-term debt, net		72,393
Long-term debt, net		$ 0

Convertible Senior Notes, Net_5

Convertible Senior Notes, Net of Current Portion, Capped Call Transactions, and Warrants - Schedule of Interest Expense Incurred (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Debt Instrument [Line Items]
Amortization of debt issuance costs and debt discount			$ 1,343	$ 2,727
Total interest expense	$ 2,400	$ 1,900		3,300
Convertible Senior Notes | Convertible Debt
Debt Instrument [Line Items]
Contractual interest expense	1,591	128	1,681	569
Amortization of debt discount	301	0	301	0
Amortization of debt issuance costs and debt discount	531	1,807	1,042	2,727
Total interest expense	$ 2,423	$ 1,935	$ 3,024	$ 3,296

Leases (Narrative) (Details)

Leases (Narrative) (Details)	Jun. 30, 2024
Minimum
Lessee, Lease, Description [Line Items]
Operating leases remaining lease term	1 year
Maximum
Lessee, Lease, Description [Line Items]
Operating leases remaining lease term	5 years

Leases (Supplemental cash flow

Leases (Supplemental cash flow information related to leases) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Leases [Abstract]
Operating cash flows for operating leases	$ 579	$ 863	$ 1,421	$ 1,837
Operating cash flows for finance leases	3	13	21	37
Financing cash flows for finance leases	$ 26	$ 968	$ 353	$ 1,926

Leases (Schedule of components

Leases (Schedule of components of lease costs) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Leases [Abstract]
Amortization of right of use assets	$ 21	$ 919	$ 355	$ 1,830
Interest	3	13	21	37
Operating lease cost	2,565	2,887	5,467	5,627
Total lease cost	$ 2,589	$ 3,819	$ 5,843	$ 7,494
Operating leases, weighted average remaining lease term (in years)	7 months 6 days	2 years 1 month 6 days	7 months 6 days	2 years 1 month 6 days
Finance leases, weighted average remaining lease term (in years)	1 year 3 months 18 days	1 year 1 month 6 days	1 year 3 months 18 days	1 year 1 month 6 days
Operating leases, weighted average discount rate (percent)	7%	7%	7%	7%
Finance leases, weighted average discount rate (percent)	7%	4%	7%	4%

Leases (Supplemental balance sh

Leases (Supplemental balance sheet information related to leases) (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
ASSETS
Operating right of use assets	$ 260	$ 4,135
Finance right of use assets	128	3,060
Current liabilities:
Operating Lease, Liability, Current	268	2,719
Finance lease liability	108	3,037
Non-current:
Operating Lease, Liability, Noncurrent	0	2,173
Finance lease liabilities	$ 28	$ 85

Fair Value Measurements - Finan

Fair Value Measurements - Financial Assets and Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Assets
Money market funds	$ 122,884	$ 174,701
Total assets	122,884	174,701
Liabilities
Warrants liability	5,266
Total liabilities	5,266
Recurring | Level 1
Assets
Money market funds	122,884
Total assets	122,884	174,701
Liabilities
Warrants liability	0
Total liabilities	0
Recurring | Level 2
Assets
Money market funds	0
Total assets	0	0
Liabilities
Warrants liability	0
Total liabilities	0
Recurring | Level 3
Assets
Money market funds	0
Total assets	0	$ 0
Liabilities
Warrants liability	5,266
Total liabilities	$ 5,266

Fair Value Measurements - Chang

Fair Value Measurements - Changes in Fair Value of Level 3 Liabilities (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Change in Fair Value of Level 3 Liabilities
Beginning balance	$ 0	$ 72,221
Payments	0	(48,993)
Issuance of warrants	5,266	0
Ending balance	5,266	0
Contingent Liability
Change in Fair Value of Level 3 Liabilities
Change in fair value of liability awards	0	4,629
Liability Awards
Change in Fair Value of Level 3 Liabilities
Change in fair value of liability awards	$ 0	$ (27,857)

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) $ in Millions	6 Months Ended
	Jun. 30, 2024 USD ($)
WildHealth
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Payments for previous acquisition	$ 12
VoiceBase, Inc.
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Payments for previous acquisition	19.9
Tenfold
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Payments for previous acquisition	9.3
ebot-7
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Payments for previous acquisition	$ 7.7

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Carrying Value and Fair Value of Debt Instruments (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
2026 Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unamortized debt discount	$ 0	$ 0
Unamortized Debt Issuance Costs		(5,935)
Net Carrying Value		511,565
2029 Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unamortized debt discount	(31,578)
2024 Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal Balance	72,000
Unamortized debt discount		0
Level 2 | 2026 Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	170,516	364,487
Principal Balance	361,204	517,500
Unamortized Debt Issuance Costs	(3,472)
Net Carrying Value	357,732
Level 2 | 2029 Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	118,122
Principal Balance	150,000
Unamortized Debt Issuance Costs	(7,488)
Net Carrying Value	$ 110,934
Level 2 | 2024 Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value		71,396
Principal Balance		72,492
Unamortized Debt Issuance Costs		(99)
Net Carrying Value		$ 72,393

Fair Value Measurements - Prici

Fair Value Measurements - Pricing Model Assumptions (Details) - Warrants	6 Months Ended
	Jun. 30, 2024 $ / shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Stock price (in dollars per share)	$ 0.62
Expected life (in years)	10 years
Historical volatility (percent)	60%
Risk-free interest rate (percent)	4.41%

Commitments and Contingencies (

Commitments and Contingencies (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Other Commitments [Line Items]
Employer matching contributions	$ 0.7	$ 0.9	$ 1.8	$ 2.3
Long-term purchase commitment, period			2 years
Letter of Credit | LOC for Security Deposit
Other Commitments [Line Items]
Letters of credit outstanding, amount	$ 0.5		$ 0.5
Match Step One
Other Commitments [Line Items]
Employer matching contribution, percent of match			100%
Employer matching contribution percent of eligible compensation			3%
Match Step Two
Other Commitments [Line Items]
Employer matching contribution, percent of match			50%
Employer matching contribution percent of eligible compensation			2%

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Stock Option Activity and Weighted Average Exercise Prices (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended	6 Months Ended
	Mar. 31, 2024	Jun. 30, 2024	Dec. 31, 2023
Options
Beginning balance (in shares)	3,137	3,137
Granted (in shares)		1,000
Cancelled or expired (in shares)		(1,256)
Ending balance (in shares)		2,881
Options vested and expected to vest (in shares)		624
Options exercisable at end of period (in shares)		1,692
Weighted Average Exercise Price
Beginning balance (in dollars per share)	$ 22.68	$ 22.68
Granted (in dollars per share)		1.02
Cancelled or expired (in dollars per share)		22.22
Ending balance (in dollars per share)		15.38
Options vested and expected to vest (in dollars per share)		6.89
Options exercisable at end of period (in dollars per share)		$ 22.51
Weighted Average Remaining Contractual Term
Weighted average remaining contract term, Options outstanding	4 years 10 months 2 days	6 years 3 months 18 days
Weighted average remaining contract term, Options vested and expected to vest		9 years 3 months 14 days
Weighted average remaining contract term, Options exercisable		4 years 1 month 13 days
Aggregate Intrinsic Value
Aggregate intrinsic value, Options outstanding		$ 1	$ 40
Aggregate intrinsic value, Options vested and expected to vest		0
Aggregate intrinsic value, Options exercisable		$ 1

Stockholders' Equity - Summar_2

Stockholders' Equity - Summary of Restricted Stock Unit Activity and Weighted Average Exercise Price (Details) - RSUs - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	6 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Number of Shares
Beginning balance outstanding (in shares)	5,064
Awarded (in shares)	5,699
Vested (in shares)	(969)
Forfeited (in shares)	(887)
Non-vested and outstanding at end of period (in shares)	8,907
Expected to vest (in shares)	6,215
Weighted Average Grant Date Fair Value (usd per share)
Beginning balance outstanding (in dollars per share)	$ 12.53
Awarded (in dollars per share)	0.99
Vested (in dollars per share)	16.66
Forfeited (in dollars per share)	15.82
Non-vested and outstanding at end of period (in dollars per share)	4.37
Expected to vest (in dollars per share)	$ 4.66
Aggregate Fair Value
Aggregate fair value, Non-vested and outstanding	$ 5,171	$ 19,193
Aggregate fair value, Expected to vest	$ 3,608

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2024	May 17, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock available for issuance (up to) (in shares)	6,920,000
Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock available for issuance (up to) (in shares)	42,367,744
Options term (in years)	10 years
Unrecognized compensation cost related to novested share-based compensation arrangements	$ 2.2
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition	1 year 8 months 12 days
Stock Option | 2019 Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, number of shares available for grant (in shares)	2,260,544
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock available for issuance (up to) (in shares)	2,000,000
Share-based compensation arrangement by share-based payment award, number of shares available for grant (in shares)	864,180
Incentive Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock available for issuance (up to) (in shares)	13,079,009
Share-based compensation arrangement by share-based payment award, number of shares available for grant (in shares)	648,450
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition	1 year 9 months 18 days
Unrecognized compensation cost related to nonvested share-based compensation arrangements	$ 27.3
Restricted stock units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Restricted stock units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	4 years
CEO Inducement Award
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock available for issuance (up to) (in shares)		1,000,000
Share-based compensation arrangement by share-based payment award, number of shares available for grant (in shares)		1,000,000
Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance	0

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Stock-Based Compensation Costs (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 5,900	$ (18,148)	$ 13,458	$ (6,816)
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	288	(1,232)	631	803
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	1,854	2,299	4,309	4,703
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	2,318	(13,882)	4,116	(11,250)
Product development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 1,440	$ (5,333)	$ 4,402	$ (1,072)

Restructuring - Narrative (Deta

Restructuring - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Restructuring and Related Activities [Abstract]
Restructuring expense	$ 3,119	$ 2,387	$ 6,428	$ 13,902

Restructuring - Schedule of Res

Restructuring - Schedule of Restructuring Reserve (Details) - USD ($) $ in Thousands	6 Months Ended	9 Months Ended
	Jun. 30, 2024	Sep. 30, 2023
Restructuring Reserve [Roll Forward]
Balance, beginning of period	$ 2,076	$ 803
IT contract termination (reversals) costs	(568)	5,744
Severance and other compensation associated costs	6,996	16,920
Cash payments	(7,160)	$ (21,391)
Balance, end of period	$ 1,344

Restructuring - Schedule of R_2

Restructuring - Schedule of Restructuring Liability by Cost Type (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring expense	$ 3,119	$ 2,387	$ 6,428	$ 13,902
Contract Termination
Restructuring Cost and Reserve [Line Items]
Restructuring expense	(1,284)	0	(568)	0
Severance and other compensation associated costs
Restructuring Cost and Reserve [Line Items]
Restructuring expense	$ 4,403	$ 2,387	$ 6,996	$ 13,902

Legal Matters (Details)

Legal Matters (Details) $ in Millions	1 Months Ended
	Feb. 29, 2024 USD ($)
Brown v. Layfield
Loss Contingencies [Line Items]
Punitive damages	$ 0.9

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Income Tax Contingency [Line Items]
Provision for (benefit from) income taxes	$ 1,258	$ (155)	$ 1,620	$ 1,059
Valuation allowance					$ 211,200
Increase in valuation allowance recorded as an expense			15,400
Accounting Standards Update 2020-06
Income Tax Contingency [Line Items]
Decrease in valuation allowance charged to equity					23,700
Foreign Tax Authority
Income Tax Contingency [Line Items]
Increase in valuation recorded					$ 23,700
Provision for (benefit from) income taxes	$ (200)		$ 1,300

Equity Method Investments (Deta

Equity Method Investments (Details) - USD ($)		3 Months Ended	6 Months Ended
	Feb. 13, 2022	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2024	Dec. 31, 2023
Schedule of Equity Method Investments [Line Items]
Equity method investment, contribution, term	5 years
Claire Holdings, Inc.
Schedule of Equity Method Investments [Line Items]
Payments to acquire equity method investments	$ 19,000,000
Ownership percentage	19.20%
Other operating income (expense), net		$ 800,000	$ 1,800,000
Equity Method Investments				$ 0	$ 0
Claire Holdings, Inc. | Pasaca Capital Inc. (“Pasaca”)
Schedule of Equity Method Investments [Line Items]
Payments to acquire equity method investments	$ 80,000,000
Ownership percentage	80.80%

Variable Interest Entity (Detai

Variable Interest Entity (Details) - corporation	Jun. 30, 2024	Feb. 28, 2022
Variable Interest Entity [Line Items]
Variable interests, number of professional corporations		4
WildHealth
Variable Interest Entity [Line Items]
Disposal group, including discontinued operation, ownership percentage in disposed asset	100%

Related Parties (Details)

Related Parties (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Related Party Transaction [Line Items]
Revenue from related parties	$ 79,875	$ 97,522	$ 165,024	$ 205,183
Accounts receivable, related parties	56,351		56,351		$ 81,802
Accounts for doubtful accounts	9,356		9,356		$ 9,290	$ 9,239
Related Party
Related Party Transaction [Line Items]
Revenue from related parties	$ 0	$ 0	$ 0	$ 3,800

Divestiture - Narrative (Detail

Divestiture - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from divestiture				$ 0	$ 13,819
Restricted cash	$ 0	$ 0		0	$ 2,679	$ 2,143
Kasamba, Inc.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from divestiture				16,900
Deferred proceeds from divestiture of business				2,600
Restricted cash						11,800
Maximum length of time, restricted cash held in escrow			15 months
Increase (decrease) of restricted investments	$ 2,000		$ 9,800	$ 1,800
WildHealth
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal group, including discontinued operation, ownership percentage in disposed asset	100%	100%		100%
Gain (loss) on disposition of business		$ (600)
Disposal Group, Held-for-sale, Not Discontinued Operations | Kasamba, Inc.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain (loss) on disposition of business						$ 17,600